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 2 
Summary 28 
With ageing, intrinsic hematopoietic stem cell (HSC) activity decreases, resulting in impaired tissue 29 
homeostasis, reduced engraftment following transplantation and increased susceptibility to diseases. However, 30 
whether ageing affects also the HSC niche impairing its capacity to support HSC function is still largely 31 
debated. 32 
Here, by using in-vivo long-term label retention assays we demonstrate that aged labelling retaining 33 
(LR) HSCs, which are in the old mice the most quiescent HSC subpopulation with the highest regenerative 34 
capacity and cellular polarity, reside predominantly in perisinusoidal niches. Furthermore, we demonstrate that 35 
sinusoidal niches are uniquely preserved in shape, morphology and number upon ageing. Finally, we show 36 
that myeloablative chemotherapy can selectively disrupt aged sinusoidal niches long term, which is linked to 37 
to the lack of recovery of endothelial Jag2 at sinusoids. 38 
Overall, our data characterize the functional alterations of the aged HSC niche and unveil that 39 
perisinusoidal niches are uniquely preserved and protect HSCs from ageing.  40 
 41 
Introduction 42 
Bone marrow (BM) HSC niches are composed of multiple haematopoietic and non-haematopoietic 43 
cells interacting in a complex 3-dimensional (3D) architecture to support HSC function1-12. Upon ageing, HSC 44 
activity decreases, resulting in impaired tissue homeostasis, reduced engraftment following transplantation and 45 
increased susceptibility to diseases and leukemia13-18.  Changes of the HSC niche upon ageing might also affect 46 
stem cell activity19. 47 
Here, to functionally characterize the interaction between BM niches and HSCs upon ageing, we 48 
employed SCL-tTAxH2B-GFP double heterozygous mice to identify aged HSCs able to retain the pulsed 49 
histone 2B-green fluorescent protein (H2BGFP) label in vivo after at least 18 months of chase (Fig. 1a; aged 50 
labelling retaining HSCs, aLR-HSCs). LR-HSCs were shown to act as a reserve stem cell population resisting 51 
chemotherapeutic challenge20-25. We demonstrate that in aged mice LR-HSCs reside predominantly in 52 
sinusoidal niches and are functionally and phenotypically younger than non-LR HSCs. We show that upon 53 
ageing HSCs are located more distant to multiple types of bone marrow niche cells but not from sinusoids and 54 
 3 
perisinusoidal Nestin(Nes)-GFPlow cells. Sinusoidal niches and Nes-GFPlow cells remain uniquely preserved in 55 
shape, morphology and number upon ageing. We show that Jag2 is expressed at sinusoids and perisinusoidal 56 
Nes-GFPlow cells in proximity to aLR-HSCs, and that blocking endothelial Jag2 promotes HSC proliferation. 57 
Finally, we demonstrate that myeloablative chemotherapy disrupts the function of aged sinusoidal niches long-58 
term, which is linked to the lack of recovery of endothelial Jag2 at sinusoids after chemotherapy and results in 59 
haematopoietic failure and decreased survival of aged mice. 60 
Overall, our data characterize the divergence in niche preservation of HSC function during ageing and 61 
unveil that perisinusoidal niches are uniquely protected, supporting aLR-HSCs located in their proximity. 62 
These findings underlie that physiological alterations of the BM niche upon ageing impact on haematopoiesis 63 
and survival particularly in the context of specific (chemo-)therapeutic interventions. 64 
 65 
Results 66 
Aged LR-HSCs are located in proximity to sinusoids. 67 
At 20 months of age, after 18 months of continuous doxycycline (DOX) chase, 0.0057 ± 0.0013% of BM cells 68 
were LR-HSCs (gated as Lin-Kit+Sca-1+Flk2-CD34-CD48-CD150+H2B-GFP+) (Supplementary Fig. 1a-d). 69 
Notably, the ageing-associated expansion of LR-HSCs was relatively modest (~3-fold) compared to ~11.8-70 
fold expansion of aged GFP- non-LR-HSCs (anLR-HSCs) (Supplementary Fig. 1e). Based on single aLR-71 
HSC transplantation assays into Rag2-/-gc-/-KitW/Wv recipient mice26, more than 80% of these cells were 72 
functional long-term HSCs (Supplementary Fig. 1f-h). Both aLR-HSCs and anLR-HSCs reconstituted hosts 73 
up to secondary transplants. However, aLR-HSCs demonstrated >8-fold higher engraftment in blood and a 74 
tendency to increased reconstitution of the stem and progenitor pool when compared to anLR-HSCs in both 75 
primary and secondary recipients, with no differences in lineage contribution (Supplementary Fig. 2a-e). 76 
aLR-HSCs were predominantly composed of young-like polar HSCs, whereas anLR-HSCs were largely apolar 77 
(Supplementary Fig. 2f-i)19, 27-29. Therefore, function and phenotypes associated with ageing characterize 78 
primarily nLR-HSCs in aged mice. 79 
We hypothesized that these “younger” LR-HSCs in the aged BM might be located at selected niches, 80 
here defined as 3D-spatial areas of the BM tissue characterized by HSCs and selected cell types lying in 81 
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proximity to each other (Fig. 1b). Young HSCs are found as individual stem cells30 in proximity to 82 
periarteriolar and perisinusoidal cells1-5 and reside frequently at the endosteal area of the BM cavity1, 6, 7 83 
associating often also with megakaryocytes (MKs)8-10. While young LR- and CD150+ LR-cells were found 84 
homogenously throughout the BM and also at the endosteal area, in agreement with previous reports21, aLR-85 
HSCs were observed always as individual stem cells mostly located close (8.1 ± 1.2 µm) to the vasculature 86 
>50µm from the endosteum (Fig. 1c, f, g and Supplementary Fig. 2j-k). In contrast, anLR-HSCs were found 87 
more frequently in clusters30, 31 and were significantly further from the vasculature (18.5 ± 1.2 µm and 21.7 ± 88 
1.0 µm, for single and clustered anLR-HSCs respectively, Fig. 1d-g). aLR-HSCs were found almost 89 
exclusively (83%) located in proximity to sinusoids, while only 19 % and 10% of single and clustered anLR-90 
HSCs were at sinusoids (Fig. 1h-j and Supplementary Video 1 and Supplementary Fig. 2l-o for the 91 
histological distinction between sinusoidal and arteriolar vessels). aLR-HSCs and anLR-HSCs weren’t located 92 
in proximity to both the endosteum and MKs (Fig. 1k-m). Therefore, aLR-HSCs are individual stem cells 93 
found selectively and specifically in proximity to perisinusoidal niches. 94 
 95 
Aged HSCs are located more distant to most niche cells, but not to perivascular Nes-GFPlow 96 
cells and sinusoids, which are uniquely preserved upon ageing. 97 
Intrigued by our findings on aLR-HSCs, we performed a more comprehensive characterization of whether the 98 
distance of HSCs from niche cells changes with ageing. In the BM endosteal region of young mice HSC 99 
frequency was >2-fold higher compared to aged mice and HSCs were significantly more distant from the 100 
endosteum (Fig. 2a-d, Supplementary Fig. 3a, Supplementary Table 1). As previously reported8, 10, 26 ± 101 
2% of HSCs in the young BM were in proximity to MKs, while in the aged setting, only 10.3 ± 2.1% of HSCs 102 
were located near to MKs (Supplementary Fig. 3b-e). In aged mice, the frequency of HSCs in proximity to 103 
Nes-GFPhigh cells was also significantly reduced, while the frequency of HSCs adjacent to Nes-GFPlow cells 104 
was unaltered. Therefore, the mean distance of HSCs to the nearest Nes-GFPhigh cell was increased in old BM, 105 
whereas the mean distance to the nearest Nes-GFPlow cell was not changed (Fig. 2e and Supplementary Fig. 106 
3f-k). Most Nes-GFPlow cells were Leptin Receptor+ (LepR+) and the distance of HSCs to perisinusoidal LepR+ 107 
cells in young and aged BM was similar (Supplementary Fig. 3l-o). Furthermore, HSCs were located equally 108 
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distant to the vasculature in young and old BM, while HSCs in aged mice were more distant from arterioles 109 
but not from sinusoids (Fig. 2f-g, Supplementary Fig. 3p-r and Supplementary Video 2-5). The frequency 110 
and localization of Ki67+ HSCs in young and aged BM was comparable (Supplementary Fig. 4a-b and 111 
Supplementary Table 2). Thus, HSCs in aged bone marrow lose proximity to multiple niche cells, but not to 112 
sinusoids and perisinusoidal Nes-GFPlow cells.  113 
Next, we investigated the extent to which ageing alters the number and the architecture of the different 114 
niche cells. In both central and endosteal BM preparations7, 12, Nes-GFPhigh cells were significantly decreased 115 
upon ageing, while the frequency of Nes-GFPlow cells remained similar (Fig. 2i-l and Supplementary Fig. 116 
4c). The number of megakaryocytes (MKs) was increased (Fig. 2m-n and Supplementary Fig. 4d-e). The 117 
frequency of endothelial cells (ECs) in the endosteal area was significantly decreased, even though the overall 118 
vasculature volume and the endothelial area occupancy was not altered (Fig. 2o-r and Supplementary Fig. 119 
4f-h). Interestingly, the aged epiphyseal/metaphyseal BM vasculature, which is mainly comprised of arteries 120 
and arterioles32, presented with a decreased length and diameter and a disorganized orientation of the vessels 121 
in aged BM (Fig. 2s-v). The aged BM diaphyseal area, which is located in the central bone and harbors the 122 
vast majority of the sinusoidal vessels32, 33, was not altered in diameter, length and orientation of vessels (Fig. 123 
2s, w-y). Therefore, sinusoidal/Nes-GFPlow cells in aged animals, which harbor LR-HSCs (Fig. 1h), are 124 
selectively not altered with respect to architecture and number upon ageing. 125 
 126 
HSC proximity to selected niche cells is not random and endothelial Jag2 maintains aged LR-127 
HSCs at sinusoids 128 
We performed in-silico modelling to investigate the relationship between changes in niche structure, and the 129 
decreased HSC proximity upon ageing. First, we simulated the distribution of 10,000 HSCs randomly placed 130 
within the BM cavity and calculated the distance between these randomly placed cells and the different niche 131 
structures (indicated as “expected” or “in silico” samples). The position of the HSCs was randomly simulated 132 
on the bases of each specific niche structure (see Methods for further details). Second, we compared the 133 
simulated random distributions (“expected”) with our 3D histological data. Based on this analysis, we could 134 
determine that the localization of HSCs is not random in both young and aged BM with respect to all the 135 
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selected niche cells (Fig. 3a and Supplementary Fig. 4h-k). Then, we analyzed the changes in distances 136 
between expected (“in-silico” computationally generated) young and aged samples. For Nes-GFPhigh cells and 137 
the endosteum the increase in in-silico predicted distance agrees with the observed histological data, suggesting 138 
that the change in HSC distance is due mainly to the systematic changes in structure and/or distribution of 139 
these niche cells (Fig. 3b, d and Supplementary Fig 4l-m). Both the in-silico model and the histological data 140 
indicated that the distance from Nes-GFPlow cells was not altered (Fig. 3c-d). With regards to MKs, the model 141 
did not predict changes with ageing, indicating that the observed increased distance is not driven by structural 142 
changes in MKs (Fig. 3d and Supplementary Fig. 4m). 143 
To further validate the relevance of the HSC position with respect to niche cells, we assessed if we can predict 144 
based on the relative distance to various niche cells if a HSC is young or aged. To this aim, we performed a 145 
keras/tensorFlow multilayer deep learning analysis based on the 7 different distance measurements of HSCs 146 
from vasculature, endosteum, NesGFPlow, NesGFPhigh, Megakaryocytes (MK), LepR+, and distance between 147 
HSCs. Though each of these histological measurements were collected on hundreds of cells, not all 148 
measurements were done simultaneously for a given cell. To address this in a robust and multivariate manner, 149 
we subsampled data from each measurement and merged them into a matrix for every training step of the 150 
model (see Methods for further details). The model was then sequentially trained for 50 rounds (iterations), 151 
each iteration (50 epochs) taking new sampling data of the training set. Validation was done on a subset of 152 
data not seen by the model. We observed close to 70% prediction accuracy in the first iteration, which linearly 153 
increased to 82.5% after 50 rounds of iteration (Fig. 3e-f). To assess the model improvement efficiency with 154 
every round of subsampling, we binned the results into 10 groups (each with 5 iterations). A correlation 155 
analysis between the median accuracy of the bins and their ordered/ranked version (smallest to largest) was 156 
statistically highly significant, indicating that the model significantly and linearly improved over the iterations 157 
considered (Fig. 3e). When we assessed the confusion table (degree of match between empirical and predicted 158 
HSCs), we saw that the model is predicting equally well if a HSC is young or aged and the rate of 159 
misclassification in the validation set was comparable (14.8% of mis-classified young HSCs and 18.8% of 160 
mis-classified aged HSCs; Fig. 3f). In the final step, we looked at the overall relevance of each niche cell type 161 
in the prediction analysis. All parameters were positively correlated and there was no significant difference 162 
between their correlation coefficients (Fig. 3g), indicating that none of the niche cells is individually important 163 
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but they need to be considered simultaneously (Fig. 3g and Supplementary Fig. 5). Therefore, according to 164 
our deep learning approach the proximity of selected niche cells to HSCs can be successfully used to predict 165 
whether a given stem cell is young or old. 166 
To additionally support proximity to specific cell types as a critical aspect to characterize whether 167 
young and aged niches are functionally different, we performed competitive young and aged HSC transplants 168 
into not irradiated young and aged Rag2-/-gc-/-KitW/Wv recipient mice (Fig. 3h). The histological data and PB 169 
data showed that in young recipients, young and aged HSCs localize with significantly different frequency in 170 
proximity to arterioles/endosteum compared to sinusoids, while in aged recipients both young and aged HSCs 171 
localize with the same frequency at sinusoids (Fig. 3i-k and Supplementary Fig. 6a-f). Despite the intrinsic 172 
difference, both young and aged HSCs function as stem cells (Supplementary Fig. 6g-h). Therefore, the data 173 
substantiate the in-silico model showing that HSC proximity to selected niche cells is not random and at least 174 
in young mice, young and aged HSCs are found in different functional niches. In addition, the data indicate 175 
that in aged mice the endosteal/arteriolar niche is functionally disadvantaged compared to the sinusoidal niche. 176 
Next, we performed single-cell RNA sequencing (scRNA-seq) on aLR-HSCs, that locate almost 177 
exclusively at sinusoids (Fig. 1h and Supplementary Fig. 6i). Similar to our functional data, when analysed 178 
together with scRNA-seq dataset from young HSCs23, LR-HSCs from aged mice were transcriptionally 179 
younger than nLR-HSCs (Fig. 4a). A total of 1058 genes were up regulated in aLR-HSCs compared to anLR-180 
HSCs, including Cxcr434, 35, Dek36, Gpr5637, 38 and Ctnnb1 (Fig. 4b and Supplementary Fig. 6j-o and 181 
Supplementary Table 3). Consistent with a younger transcriptome in LR-HSCs from aged mice, GO analyses 182 
revealed an enrichment for canonical Wnt and cell polarity establishment27, which are associated with young 183 
HSCs28, 30 (Fig. 4c). Of note, there was also increased expression of Rbpj and Hes1 critically linked to canonical 184 
Notch signalling39-41 (Fig. 4d). Notch signaling in HSCs is engaged by Jag/Dll ligands on juxtaposed cells and 185 
requires cell proximity42. Supporting that active Notch signaling might be critical for LR-HSCs proximity at 186 
sinusoidal niches, we observed high levels of Jag2 at sinusoids and Nes-GFPlow cells in young and especially 187 
in aged BM, as well as at sinusoids that were in proximity to aLR cells (Fig. 4e and Supplementary Video 188 
6). Jag2 levels were markedly reduced in aged Nes-GFPhigh/arteriolar cells in aged mice (Fig. 4f). Flow 189 
cytometry analyses revealed that the frequency of Jag2+Nes-GFPlow and Jag2+ECs was preserved in aged mice, 190 
while there was a more than 2-fold decrease in the frequency of Jag2+Nes-GFPhigh cells. The maintenance of 191 
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Jag2 expression in sinusoids upon ageing was specific to Jag2. For example, Jag1 was found to be significantly 192 
reduced in aged sinusoids and endothelium (Fig. 4g-i and Supplementary Fig. 7a-b). Dll1 and Dll4 were 193 
barely detectable and not changed with ageing (Fig. 4g-i and data not shown). To determine the role of 194 
endothelial Jag2 for HSC function, first we performed in vitro co-culture experiments. Blocking endothelial-195 
derived Jag2 markedly increased the number and thus proliferation of HSCs (Supplementary Fig. 7c-f). 196 
Second, we injected the Jag2-blocking antibody directly in aged mice (Fig. 4j). In BM, the Jag2-blocking 197 
antibody showed a very specific staining pattern similar to the Jag2 distribution detected by histology and flow 198 
cytometry analysis, binding mainly aged endothelial sinusoids (Supplementary Fig. 7g). Consistently with 199 
the in vitro data, blocking Jag2 in vivo induced in the diaphyseal central BM higher proliferation of aged HSCs 200 
and clustering at sinusoids (Fig. 4k-n and Supplementary Fig. 7h). Overall, in this region the frequency of 201 
sinusoidal Ki67+ HSCs doubled (Fig. 4m and Supplementary Fig. 7i-j) and the effect was almost exclusively 202 
localized at sinusoids (Supplementary Fig. 7i-k), resulting in a significant increase in the frequency of 203 
clustered HSCs in proximity to sinusoidal niches (Supplementary Fig. 7k), which are normally extremely 204 
rare in control condition. In summary, our data show that Jag2 is expressed at sinusoids and by Nes-GFPlow 205 
cells in aged BM in proximity to aLR-HSCs and that endothelial Jag2 suppresses HSC proliferation and 206 
clustering.  207 
 208 
5-FU treatment specifically disrupts sinusoidal niches and impairs haematopoiesis and survival 209 
of aged mice 210 
To functionally investigate the sinusoidal niche in aged animals, we performed treatments with 5-fluorouracile 211 
(5-FU), which in young mice results in damage to sinusoidal niches as well as myelosuppression43-45. The aged 212 
sinusoidal niche was also dramatically compromised by 5-FU, with markedly reduced cellularity and increased 213 
diameter of the sinusoidal vessels (Supplementary Fig. 8a and Fig. 5a-d). However, the arterioles and the 214 
endosteal niche were largely unaffected by 5-FU, particularly so in the case of aged mice (Fig. 5d-f). The 215 
sinusoidal disruption correlated with a reduction in Nes-GFPlow cells in the aged mice only, whereas Nes-216 
GFPhigh cells remained unaltered after 5-FU (Fig. 5g-h). The percentage of cycling HSCs after 5-FU remained 217 
very low in aged mice and we didn’t observe clusters of proliferative MPPs. In contrast, 62.7% of HSCs in 218 
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young 5-FU treated mice were actively cycling (Ki-67+) and we detected numerous clusters of proliferating 219 
MPPs. Of note, HSCs from aged mice transplanted in a young niche showed an increase in the frequency of 220 
Ki-67+ HSCs after 5-FU, supporting a critical and dominant role of the young niche for the activation of HSCs 221 
after myelosuppression (Fig. 5i-j and Supplementary Fig. 8b-c). While haematopoiesis recovered within 30 222 
days of 5-FU treatment, after 4-5 months aged 5-FU treated mice showed a significant decrease in white blood 223 
cells associated with a reduction in long-term survival post treatment, suggesting that the HSC compartment 224 
may be compromised (Fig. 5k-l and Supplementary Fig. 8d). To exclude the possibility that 5-FU might 225 
directly damage the HSCs, we performed transplantations of young and aged recipient mice preconditioned by 226 
5-FU. We detected very low/absent engraftment in 5-FU preconditioned young and aged mice, while irradiated 227 
recipients (11Gy) were efficiently engrafted. These data indicate that endogenous HSCs in 5-FU 228 
preconditioned recipients were not directly affected by the chemotherapy (Fig. 5m and Supplementary Fig. 229 
8e-f). Of note, sinusoids remained significantly enlarged in aged mice still 30 days after 5-FU treatment 230 
(Supplementary Fig. 8g-h). scRNA-seq of sorted young and aged ECs showed largely overlapping 231 
transcriptome profiles with few differentially expressed genes, mainly indicating a lack of proliferating ECs 232 
within the aged samples (Supplementary Fig. 8i-k and Supplementary Table 4). Interestingly, Jag2 233 
expression did not recover in the aged sinusoidal niche after 5-FU and HSCs localized significantly farther 234 
away from sinusoids, while their proximity to arterioles increased (Fig. 5n-p). Considering that we detected 235 
no change in the frequency and proliferation rate of HSCs in the aged BM after 5-FU (Fig. 5j and 236 
Supplementary Fig. 8l-m), we conclude that HSCs likely relocated to the arteriolar niche. Since young mice 237 
fully recover after 5-FU treatment (Fig. 5l) and 5-FU did not directly affect HSCs in both young and aged mice 238 
(Fig. 5m), our data strongly support that the Jag2+ sinusoidal niche is critical for maintaining functional HSCs 239 
in aged animals.  240 
 241 
Discussion 242 
Collectively, our data imply that aLR-HSCs, when compared to anLR-HSCs, present with the highest 243 
regenerative potential; a less pronounced expansion compared to young cells; an absence of clustering; high 244 
cytosol and epigenetic polarity; canonical Wnt signaling; an overall “younger” transcriptome profile. In 245 
addition, we show here that aLR-HSCs are exclusively found at sinusoidal niches, that are central for 246 
 10 
maintaining haematopoiesis in aged mice. Transplantation assays, histological data and in silico modelling all 247 
convey that the perisinusoidal/Nes-GFPlow niche is uniquely phenotypically and functionally preserved upon 248 
ageing, while in general most niches and the proximity of HSCs to niche cells are significantly altered upon 249 
ageing (Supplementary Fig. 9a). To note, according to our deep learning approach the proximity of selected 250 
niche cells to HSCs can be successfully used even to predict whether a given stem cell is young or old. 251 
In light of a supportive contribution of the niche to the intrinsic function of HSCs46, our data strongly imply 252 
that the sinusoidal/Nes-GFPlow niche in aged mice, via Jag2 signaling, preserves a more pristine function of 253 
HSCs located close to it. The deficiency in endothelial Jag2 recovery after 5-FU treatment (Fig. 5n-o) might 254 
be one critical aspect defeating haematopoietic stem cell functional preservation in old mice. These data are 255 
surprising when considering previous findings ruling out a significant effect of cell-autonomous canonical 256 
Notch signaling on HSC maintenance in vivo47. However, haematopoietic stress and inflammation, as after 5-257 
FU treatment and ageing, were not directly investigated. Our data are consistent indeed with a more recent 258 
report highlighting specifically the importance of endothelial Jag2 after myelosuppression48.  Collectively, 259 
these findings add critically to our understanding of how a specific BM niche can impact on HSC fate in the 260 
elderly in general and particularly in the context of specific chemotherapeutic interventions.  261 
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Methods 262 
Mice. SCL-tTAxH2B-GFP double heterozygous mice bones were obtained from the Milsom’s laboratory 263 
(Deutsches Krebsforschungszentrum, Division of Experimental Hematology, Heidelberg, Germany). 264 
Technical details on mouse DOX treatment were previously described22. Nes-GFP transgenic mouse line was 265 
obtained from the Méndez-Ferrer’s laboratory (Wellcome Trust-Medical Research Council Cambridge Stem 266 
Cell Institute and Department of Hematology, University of Cambridge, Cambridge, United Kingdom). 267 
C57BL/6 mice (8-16-week-old) were obtained from Janvier. Aged C57BL/6 mice (20-26-month-old) were 268 
obtained from the internal divisional stock (derived from mice obtained from both The Jackson Laboratory 269 
and Janvier) as well as from NIA/Charles River. Rag2-/-gc-/-KitW/Wv mice were obtained from the internal 270 
divisional stock (derived from mice obtained from Hans-Reimer Rodewald26). Young and aged AcRFP and 271 
AcYFP mice were obtained from the internal divisional stock (derived from mice obtained from Prof. Hans 272 
Joerg Fehling, Institute of Immunology, Ulm University, Germany). Briefly, Pan-YFP mice carrying 273 
constitutively active ROSA26-tdYFP alleles (indicated in the manuscript as AcYFP mice) were obtained from 274 
Prof. Hans Joerg Fehling (Institute of Immunology, Ulm University) and were previously generated by 275 
intercrossing C57BL/6-Gt(ROSA)26Sortm1Hjf/Ieg mice49 with animals from a germline Cre-deleter strain50. 276 
Offspring in which the ROSA26-driven fluorescent tdYFP reporter had been activated irreversibly as the result 277 
of loxP/Cre-mediated recombination in the germline were backcrossed for > 10 generations onto C57BL/6, 278 
thereby eliminating the Cre recombinase transgene. AcYFP mice were used as homozygotes. Young AcCFP 279 
mice were obtained from the internal divisional stock (derived from mice obtained from Dr. Yi Zheng, 280 
Cincinnati Children Hospital Medical Centre, Cincinnati, Ohio, USA). All mice were housed in the animal 281 
barrier facility under pathogen-free conditions at the University of Ulm.  Throughout the manuscript young 282 
mice are between 10 and 16-week-old and aged mice are at least 80-week-old. To induce myeloablation by 5-283 
FU, mice were intraperitoneally administered one dose of 5-FU (150mg/kg).  Young mice were treated with 284 
5-FU at 10 weeks of age; old mice were treated with 5-FU at 76 week of age. Mice for this study were randomly 285 
selected and survival was followed up to 270 days after 5-FU administration. To assess the statistical 286 
significance of differences in survival, we performed Log Rank Mantel Cox test. All statistical tests were 287 
performed using GraphPad with Prism7, following its Statistics Guide. 288 
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All mouse experiments were performed in compliance with the German Law for Welfare of Laboratory 289 
Animals and were approved by the Institutional Review Board of the University of Ulm. 290 
 291 
Flow cytometry and cell sorting. PB and BM cell immunostaining was performed according to standard 292 
procedures and samples were analyzed on a LSRII flow cytometer (BD Biosciences). Monoclonal antibodies 293 
to Ly5.2 (clone 104, eBioscience) and Ly5.1 (clone A20, eBioscience) were used to distinguish recipient from 294 
donor cells. For PB and BM lineage analysis the antibodies used were all from eBioscience: anti-CD3ε (clone 295 
145-2C11), anti-B220 (clone RA3-6B2), anti-Mac-1 (clone M1/70) and anti-Gr-1 (clone RC57BL/6-8C5). 296 
Lineage FACS analysis data are plotted as the percentage of B220+, CD3+ and Myeloid (Gr-1+, Mac-1+ and 297 
Gr-1+ Mac-1+) cells among donor-derived cells in case of a transplantation experiment or among total white 298 
blood cells. Gating strategy is according to Supplementary Fig. 9e. As for early haematopoiesis analysis, 299 
mononuclear cells were isolated by low-density centrifugation (Histopaque 1083, Sigma) and stained with a 300 
cocktail of biotinylated lineage antibodies. Biotinylated antibodies used for lineage staining were all rat anti-301 
mouse antibodies: anti-CD11b (clone M1/70), anti-B220 (clone RA3-6B2), anti-CD5 (clone 53-7.3) anti-Gr-302 
1 (clone RB6-8C5), anti-Ter119 and anti-CD8a (Clone 53-6.7) (all from eBioscience). After lineage depletion 303 
by magnetic separation (Dynalbeads, Invitrogen), cells were stained with anti-Sca-1 (clone D7) (eBioscience), 304 
anti-c-kit (clone 2B8) (eBioscience), anti-CD34 (clone RAM34) (eBioscience), anti-CD127 (clone A7R34) 305 
(eBioscience), anti-Flk-2 (clone A2F10) (eBioscience), anti CD48 (clone HM48-1, BioLegend), anti-CD150 306 
(clone TC15-12F12.2, BioLegend) and Streptavidin (eBioscience). Early haematopoiesis FACS analysis data 307 
were plotted as percentage of long-term haematopoietic stem cells (HSCs, gated as LSK CD34-/low Flk2- CD48- 308 
CD150+), short-term haematopoietic stem cells (ST-HSCs, gated as LSK CD34+ Flk2-) and lymphoid-primed 309 
multipotent progenitors (LMPPs, gated as LSK CD34+ Flk2+)43 distribution among donor-derived LSKs (Lin- 310 
c-kit+ Sca-1+ cells). In order to isolate HSCs, lineage depletion was performed to enrich for lineage negative 311 
cells. Lineage negative cells were then stained as aforementioned and sorted using a BD FACS Aria III (BD 312 
Bioscience).  313 
For investigating Notch ligands expression on BM stromal cells, endothelial cells and Nes-GFP+ cells were 314 
gated according to Supplementary Fig. 9b, d. Additional antibody staining was performed with anti-Jag1 315 
APC (clone HMJ1-29 BioLegend), anti-Jag2 eFluor660 (clone HMJ2-1, Invitrogen), anti-Dll1 APC (HMD1-316 
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3, BioLegend) and the percentage of positive cells was gated against isotype control (APC Armenian Hamster 317 
IgG, BioLegend; eFluor660 Armenian Hamster IgG, ebioscience) stained matching samples. 318 
 319 
Whole-mount immunofluorescence staining. After optional i.v. injection of APC-anti-CD31 (clone 320 
MEC13.3, BioLegend) and Alexa Fluor® 647-anti-CD144 (clone BV13, BioLegend) antibodies, bones were 321 
harvested after post-mortem heart perfusion with 4% paraformaldehyde (PFA) in phosphate-buffered saline 322 
(PBS) and were post-fixed in 4% PFA/PBS-solution for 24h at 4°C. Subsequently, bones were embedded 323 
without bisecting in optimum cutting temperature compound (O.C.T., Tissue-Tek®) and were snap frozen in 324 
liquid nitrogen and stored at -80°C. Bones were shaved along the longitudinal axis on a cryostat until the BM 325 
cavity was exposed. The bones were purified from melting O.C.T. Specimens were fixed again in 4% PFA/PBS 326 
at RT for 30 minutes. Tissues were blocked and permeabilized with buffer containing 20% donkey serum and 327 
0.5% Triton X-100, were incubated with a fluorescently labeled antibody PE-anti-CD150 or Alexa Fluor® 328 
488-anti-CD150 (both clone TC15-12F12.2, BioLegend) and Biotin-labeled primary antibodies anti-CD41 329 
(clone MWReg30), anti-CD48 (clone HM48-1), anti-CD11b (clone M1/70), anti-B220 (clone RA3-6B2), anti-330 
CD5 (clone 53-7.3) anti-Gr-1 (clone RB6-8C5), anti-Ter-119 and anti-CD8a (Clone 53-6.7) (all from 331 
eBioscience) 1-3 days at 4°C and stained with Streptavidin-eFluor®450 (eBioscience), Streptavidin-FITC 332 
(eBioscience) or Streptavidin-APC (eBioscience)  for 2h at RT. For BM staining, shaved bones were incubated 333 
with FITC-anti-Ki-67 (clone SolA15, ebioscience), armenian-hamster-PE-anti-mouse DLL4 (clone HMD4-1, 334 
BioLegend), armenian-hamster-PE-anti-mouse DLL1 (clone HMD1-5, ebioscience) or primary antibodies 335 
goat-anti-FABP4 (R&D Systems), biotinylated anti-CD41 (clone MWReg30, ebioscience), rabbit-anti-Jag2 336 
(clone EPR3646, Abcam) or rabbit-anti-Jag1 (polyclonal, Abcam) 1-2 days at 4°C and stained with secondary 337 
antibodies Streptavidin-eFluor®450 (eBioscience) or fluorescently labeled donkey-anti-goat, donkey-anti-338 
rabbit and donkey anti-armenian hamster antibodies (from Jackson ImmunoResearch) for 2h at RT. If 339 
necessary, the nuclei were counterstained with DAPI. The fluorescently labeled bone tissues were placed cut-340 
face down onto a 4-well-µ-Slide and were covered in antifade or PBS to prevent tissue desiccation. The 341 
preparations were examined under Zeiss LSM 710 or Leica TCS SP8 confocal microscopes and analysed with 342 
the image analysis software Volocity (v6.2, Perkin Elmer). The nearest distances from HSCs to multiple niche 343 
cell types were measured. The term arteriole includes arterial and arteriolar cell. 2-photon imaging was 344 
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performed on cryo-shaved long bones using an upright Zeiss 7MP microscope. 2-photon excitation at 800 nm 345 
was achieved with a Mai Tai DeepSee Ti:Sa laser (Spectra-Physics) and fluorescence was detected using the 346 
BP 500-550 filter to detect green signal (GFP). For second-harmonic generation microscopy a BP485 filter 347 
was used to detect blue signal. To visualize the microvasculature, we injected in vivo labeled PECAM-1 348 
(CD31) and VE-Cadherin (CD144) antibodies or used FABP4 in situ9. LepR+ cells were stained with anti-349 
mouse Leptin R antibody from R&D Systems AF497. As for the proximity of HSCs to LepR+ cells, we took 350 
into consideration only the distance between HSCs and the nearest perivascular LepR+. When it was not 351 
possible to match the nearest LepR+ process to an associated perivascular LepR+ cell, we took the nearest 352 
perivascular LepR+ cell body. For the Jag2 in vivo blocking histological analysis, the images with the highest 353 
HSC numbers in the distal-diaphyseal-femoral central BM were taken in consideration.  354 
 355 
Immunofluorescence staining. Freshly sorted HSCs were seeded on fibronectin-coated glass coverslips. 356 
After culturing cells were fixed with BD Cytofix Fixation Buffer (BD Biosciences). After fixation cells were 357 
gently washed with PBS, permeabilized with 0.2% Triton X-100 (Sigma) in PBS for 20 minutes and blocked 358 
with 10% Donkey Serum (Sigma) for 30 minutes. Primary and secondary antibodies incubations were 359 
performed for 1hr at room temperature. Coverslips were mounted with ProLong Gold Antifade Reagent with 360 
or without DAPI (Invitrogen, Molecular Probes). The secondary antibodies for IF were anti-rat DyLight488-361 
conjugated antibody, anti-rat DyLight647-conjugated antibody and anti-rabbit DyLight549-conjugated 362 
antibody (all obtained from Jackson ImmunoResearch). Samples were imaged with an AxioObserver Z1 363 
microscope (Zeiss) equipped with a 63X PH objective. Images were analysed with Zen software. Alternatively, 364 
samples were analysed with an LSM710 confocal microscope (Zeiss) equipped with a 63X objective. Primary 365 
raw data were imported into the Volocity Software package (Version 6.2, Perkin Elmer) for further processing 366 
and conversion into 3-dimensional images. On average a total of 20 dividing HSCs were singularly analysed 367 
per sample. The primary antibodies were anti-alpha tubulin antibody (Abcam, rat monoclonal ab6160) anti-368 
Cdc42 and anti-H4K16ac obtained from Millipore and Abcam (we tested two different antibodies for each 369 
target; results were consistent. All 4 antibodies were rabbit polyclonal; anti-Cdc42 from Millipore was 370 
previously validated27, 28). 371 
 372 
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Endosteal and central BM cell population isolation. To isolate central BM cells and endosteal BM cells 373 
close to the endosteum, femora and tibiae were isolated from young and aged mice. The bones were cleaned 374 
and the associated muscle tissues removed. After the bone marrow was flushed out and lysed by RBC buffer 375 
(BioLegend) the central BM cells were obtained. The flushed bones were mortared and incubated in 1.5 mg 376 
ml collagenase IV (Worthington)/PBS for 1.5 h at 37°C. This endosteal BM cell fraction was filtered through 377 
a 70µm cell strainer and counted. Central and endosteal BM cell fractions were stained with CD45.2 378 
Monoclonal Antibody (104) PerCP-Cyanine5.5 conjugated (eBioscience), CD31-APC (BioLegend) and 379 
CD41-biotinylated+SA-FITC (eBioscience).  Gating strategy is according to Supplementary Fig. 9b-d. 380 
 381 
BM endothelial cell culture and HSC-endothelial cell co-culture. BM endothelial were prepared from 382 
young BL6.SJL mice according to51. Briefly, after red blood cell lysis, BM cells were seeded on Fibronectin 383 
(Takara, 1µg/µl) coated 24-well plates in endothelial Medium: DMEM-HAM's F-12 (Sigma, D6421), 384 
20%FBS, 1%P/S, 20mM HEPES, 10µg/ml Heparin, 50µg/ml Endothelial Mitogen (Alfa Aeser #J65416), 5µM 385 
SB431542 (R&D, #1614) and cultured at 37°C, 5%CO2, 3%O2, with medium change every other day. After 6 386 
days of culture, 75-90% of the cells were CD31+ endothelial cells according to FACS-analysis and to cell 387 
morphology. For co-culture experiments, 2000-3000 sorted YFP+HSCs (prepared as aforementioned from 388 
AcYFP mice) were seeded on top of 6-day cultured BM endothelial cells and the endothelial medium was 389 
supplemented with SCF, G-CSF, TPO 100ng/ml each + Jag2 blocking antibody (Bio X Cell BE012552, 390 
10µg/ml) or Isotype control antibody (eBioscience 14-4888-85, 10µg/ml). HSCs cultured without endothelial 391 
cells in the same medium with Jag2 blocking antibody or isotype served as control. After 44-46h of co-culture, 392 
cells were harvested and the number of HSCs was assessed by FACS. 393 
 394 
Preparation of binary vector maps. The in silico simulation was performed based on binary structure maps 395 
generated from processed histological data. For this, we prepared whole-mount, long bone marrow sections of 396 
young and aged Bl6 mice. We stained for different niche cell populations by immunofluorescent labelling (see 397 
corresponding section in Materials & Methods) and recorded confocal images. The z-stack images (z-level 398 
depth of 50 µm) were converted to two-dimensional extended-focus representations using the imaging 399 
software Volocity. Based on structure-specific immunoflourescent signal and morphology, the images were 400 
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then cleaned from secondary structures and cells, resulting in binary vector maps containing only the respective 401 
niche structure and a structure-free domain (see also Supplementary Fig. 4h). For each niche structure, at 402 
least three young and three aged maps were analysed, each covering an area of at least 330 x 770 µm with a 403 
resolution of at least 3 pixels/µm. The maps were obtained from two animals per niche structure and age group. 	404 
 405 
In silico simulation. We generated distance distributions, representing the expected distance of HSCs towards 406 
the endosteum, NesGFPhigh cells, NesGFPlow cells and MKs in the young and aged setting, under the 407 
presumption of random localization and choice of position. For each map we randomly selected 10,000 408 
positions in the structure-free domain and recorded the Euclidean distance towards the borders of the respective 409 
niche structure. To eliminate boundary artifacts, sampled positions within 25 µm of the map edges were 410 
removed and resampled. One representative random distribution was drawn per niche structure and age group 411 
by resampling the random distributions calculated for each map of said structure/group for a total of 10,000 412 
data points. Those representative random distributions were then used to (i) assess the randomness of 413 
localization of HSCs by comparing the observed distances (in situ) to the expected random distances (in silico). 414 
In a second step, we (ii) compared the changes in random distance between young and aged within the in silico 415 
system. In this way, we were able to assess the systematic effect of structural changes of each isolated niche 416 
component, occurring with ageing, and predict changes in distance towards HSCs. The statistical significance 417 
of the null hypothesis that both compared distributions are derived from the same statistical population was 418 
analysed using two-sample Kolmogorov-Smirnov. The significance levels were set to 0.05 for the comparison 419 
observed vs. observed, 1E-3 for observed vs. expected and 1E-8 for expected vs. expected. The effect size D 420 
indicates the supremum absolute (vertical) distance between the compared CDFs and is provided for each 421 
comparison. 422 
 423 
Keras/TensorFlow multilayer deep learning. We employed a keras/TensorFlow binary classification model 424 
to predict young and aged HSC based on 7 different distance measurements within the niche. We had an initial 425 
layer of 16 units, 3 hidden layers (16 units), and a final output layer of 1 unit (binary output). Glorot uniform 426 
initializer was used for kernel initialization while hyperbolic tangent Activation was employed for kernel 427 
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activation. Stochastic gradient descent (sgd) optimizer was used for model optimization with binary 428 
crossentropy loss measurement. The sequential model was trained by sampling data from each parameter (61 429 
cases of young and 88 cases of aged for each iteration composed of 50 epochs), and was trained for a total of 430 
50 iterations. A total of 80 cases (33 young and 47 aged HSCs) were put aside as a validation set. A bootstrap 431 
analysis of the validation set (500 iterations) was later used for the parameter relevance correlation analysis. 432 
 433 
Single cell RNA preparation (LR-HSCs and nLR-HSCs). Single LT-HSCs were sorted based on GFP 434 
expression (positive and negative). Cells were cultured overnight without growth factors at 3%O2 and washed 435 
twice with PBS before processing.  436 
Single cells were processed using the SMART-Seq v4 Ultra Low Input RNA Kit for Sequencing (Clontech 437 
Laboratories, Catalog # 634892) according to manufacturer’s instructions. Amplified c-DNA was purified with 438 
Agencourt AMPure XP beads (Beckman Coulter, Catalog # A63880) before library preparation with 439 
Illumina’s NextEra XT DNA Library Preparation kit (Catalog # FC-131-1096) according Illumina's 440 
instructions. Library DNA was purified with AMPure XP beads and quantified using Agilent Bioanalyser for 441 
manual library normalization. Pooled libraries were subjected to next generation sequencing in Hi-Seq 2500, 442 
for pair end 75bp sequencing condition. 443 
 444 
Single cell RNA preparation (CD31+ endothelial cells). Young and aged BM CD45-CD31+ endothelial cells 445 
were sorted from endosteal preparations into IMDM (Lonza, Catalog # BE12-722F) + 10% FCS (Sigma). Cells 446 
were frozen in IMDM+20%FCS+ 10% DMSO (Sigma). Endothelial cells were thawed, washed once in warm 447 
PBS, and subjected immediately to encapsulation in oil droplets using the chromium system by 10X Genomics. 448 
cDNA synthesis and library preparation were done according to the manufacturer’s instructions for 3’ end 449 
counting. PCR cycles for both cDNA synthesis and amplification were adjusted for each sample individually 450 
to the number of cells loaded cDNA yield respectively. Samples were pooled and sequenced on a HiSeq3000 451 
sequencer (Illumina). Five libraries were prepared in three biological replicates. 452 
 453 
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RNA-Sequencing Analysis (LR-HSCs and nLR-HSCs). Following removal of barcodes and primers, raw 454 
reads were aligned to the mm10 mouse genome with annotations provided by UCSC using a proprietary 455 
Burrow-Wheeler Transform alignment (COBWeb).  Aligned reads were used to compute reads per kilobase 456 
per million reads (RPKM) using an EM-algorithm for 38,186 transcripts.  Data were normalized using the 457 
DESeq algorithm and baselined to the median of all samples.  A moderated t-test was used to identify 458 
significantly differentially regulated genes between LR-HSCs and nLR-HSCs, with significance set at p<0.05 459 
and FC>3.  Ontological analysis was performed in ToppGene (toppgene.cchmc.org), which gathers data from 460 
over 30 ontological repositories.  Figures were generated using ToppCluster (toppcluster.cchmc.org) and 461 
Cytomap.  All data processing and analyses were performed in Strand NGS. 462 
 463 
RNA-Sequencing Cross-Analysis of aged LR-HSCs and nLR-HSCs vs. young LR-HSCs and HSCs. Raw 464 
alignment data of young LR-HSCs and HSCs published in Cabezas-Wallscheid, N. et al.23 was obtained via 465 
the accession number ArrayExpress: E-MTAB-4547. Alignment and lowlevel processing of the data was 466 
performed in parallel with our dataset of aged LR-HSCs and nLR-HSCs as described by Cabzeas-Wallscheid 467 
et al.. Cell filtering on both datasets was performed with reduced stringency (>25,000 reads and >500 detected 468 
genes per library). Diffusion map representations of log-transformed, size-factor normalized expression data 469 
were generated using the R package destiny53. 470 
 471 
RNA-Sequencing Analysis (CD31+ endothelial cells). UMI counts were generated using the Cell Ranger 472 
pipeline (10x Genomics) with default settings and the provided mm10-1.2.0 reference dataset. The cells were 473 
filtered based on total number of UMIs (>= 1000), total number of detected genes (>= 1000, at least one read) 474 
and percentage of mitochondrial reads (< 10%) using the scater toolkit54 (R package).  Lowly expressed genes 475 
were subsequently filtered out (at least 3 reads in 20 different samples). A set of 1651 out of 3384 cells passed 476 
all criteria, consisting of 1218 young and 433 aged cells covering 2517 genes. Highly variable genes (HVGs) 477 
were identified by using a log-linear fit to capture the relationship between mean and squared coefficient of 478 
variation (CV) of log-transformed, size-factor normalized data55 resulting in 1570 genes. DE analysis was 479 
performed on HVGs using DESeq256, resulting in 48 genes upregulated with ageing and 11 genes 480 
downregulated with ageing. The analysis was performed on raw counts and the likelihood ratio test with the 481 
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experimental batches as covariables was used. Dispersions were estimated using a local fit and size factors 482 
were estimated using the “poscounts” setting. Cell cycle states were scored based on a random forest trained 483 
on cell cycle markers genes using Cyclone57 (implementation in R package scran58). Diffusion map 484 
representations were generated using the R package destiny53. 485 
 486 
Stem cell transplants. For HSC transplantations in Supplementary Fig. 2a-e, aged (20-month-old and 18 487 
months under Dox chase) SCL-tTAxH2B-GFP double heterozygous mice (Ly5.1+) were used as donors and 488 
Rag2-/-gc-/-KitW/Wv mice (Ly5.2+) as recipients. From the same donor mouse 10 LR-HSCs and 10 nLR-HSCs 489 
were sorted into separated Terasaki wells. Cells were checked under the microscope before injection into the 490 
retro-orbital vein of recipient mice. From each donor mouse 3-4 recipents per each 10 LR-HSCs and 10 nLR-491 
HSCs were transplanted. A total of 4 different donor mice were used for this assay. PB chimerism was 492 
determined by FACS analysis at week 4, 12, 16 and 20 post-transplant. The transplantation experiment was 493 
performed two times with a cohort of 12-16 recipient mice per group each transplant. After 20 weeks from the 494 
primary transplant, total BM from recipient mice was harvested and reinjected into a new cohort of Rag2-/-gc-495 
/-KitW/Wv recipient mice. PB chimerism was followed as for primary transplanted mice up to 20 weeks after 496 
secondary transplantation.  497 
For the single HSC transplantations in Supplementary Fig. 1f-h, aged (20-month-old and 18 months under 498 
Dox chase) SCL-tTAxH2B-GFP double heterozygous mice (Ly5.1+) were used as donors and Rag2-/-gc-/-499 
KitW/Wv mice (Ly5.2+) as recipients. Single HSCs were sorted into Terasaki wells. Cells were checked under 500 
the microscope before injection into the retro-orbital vein of recipient mice. A total of 7 recipient mice were 501 
used for this assay. PB chimerism was determined by FACS analysis at week 4, 8 and 12 post transplant. 502 
For the HSC transplantations in Fig. 3h, aged (more than 20-month-old) acYFP and young (10-week-old) 503 
acCFP mice were used as donors. 500 HSCs from acYFP and acCFP mice were sorted together in 96 multiwell 504 
(1000 HSCs each well). Cells were checked under the microscope before injection into the retro-orbital vein 505 
of recipient mice. A total of 5 aged (more than 56-week-old) and 9 young (6-week-old) Rag2-/-gc-/-KitW/Wv mice 506 
were used as recipients. Young and aged recipient mice were transplanted alongside with the same preparation 507 
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of 500 CFP+ and 500 YFP+ HSCs. PB chimerism was determined by FACS analysis at week 6, 12 and 16 508 
post-transplant. 509 
For the HSC transplantations in Supplementary Fig. 8c, aged (more than 20-month-old) acYFP mice were 510 
used as donors. 500 HSCs from acYFP mice were sorted in 96 multiwell. Cells were checked under the 511 
microscope before injection into the retro-orbital vein of recipient mice. A total of 5 young (6-week-old) Rag2-512 
/-gc-/-KitW/Wv mice were used as recipients. After 6 weeks from transplant, young recipient mice were injected 513 
+/- 5-FU 150mg/kg and 4 days after were sacrificed for histological analysis. 514 
For the HSC transplantations in Supplementary Fig. 8e, aged (more than 20-month-old) acYFP and young 515 
(10-week-old) acYFP mice were used as donors. 500 HSCs from acYFP young and aged mice were sorted in 516 
96 multiwell (500 HSCs each well). Cells were checked under the microscope before injection into the retro-517 
orbital vein of recipient mice. A total of 5 aged (more than 56-week-old) and 9 young (6-week-old) Rag2-/-gc-518 
/-KitW/Wv mice were used as recipients. Young (12-week-old) and aged (80-week-old) recipient C57Bl6 mice 519 
were transplanted after either 11Gy irradiation, 4-day-5-FU injection or no pre-conditioning. Young HSCs 520 
were transplanted into young recipients and aged HSCs were transplanted into aged recipients. PB chimerism 521 
was determined by FACS analysis at week 3, 6, 9 and 12 post-transplant. 522 
 523 
Statistical analysis. 524 
All data are plotted as mean ± standard error (s.e.m.). A paired Student's t-test was used to determine the 525 
significance of the difference between means of two groups. One-way ANOVA or two-way ANOVA were 526 
used to compare means among three or more independent groups. The variance was similar between groups 527 
that were statistically compared. Distance analysis data were analyzed using a Mann-Whitney U test when 528 
non-Gaussian distribution was observed (tested by Shapiro-Wilk and D’Agostino-Pearson omnibus test). 529 
Bonferroni post-test to compare all pairs of data set was determined when overall P-value was < 0.05. All 530 
statistical analyses were determined with Prism 7.0 version. In each figure legend, the number (n) of biological 531 
repeats included in the final statistical analysis is indicated. Mice for experiments were randomly chosen from 532 
our in-house colonies or suppliers. 533 
 21 
References 534 
1. Kunisaki, Y. et al. Arteriolar niches maintain haematopoietic stem cell quiescence. Nature 535 
502, 637-643 (2013). 536 
2. Ding, L., Saunders, T.L., Enikolopov, G. & Morrison, S.J. Endothelial and perivascular cells 537 
maintain haematopoietic stem cells. Nature 481, 457-462 (2012). 538 
3. Acar, M. et al. Deep imaging of bone marrow shows non-dividing stem cells are mainly 539 
perisinusoidal. Nature 526, 126-130 (2015). 540 
4. Itkin, T. et al. Distinct bone marrow blood vessels differentially regulate haematopoiesis. 541 
Nature 532, 323-328 (2016). 542 
5. Chen, J.Y. et al. Hoxb5 marks long-term haematopoietic stem cells and reveals a homogenous 543 
perivascular niche. Nature 530, 223-227 (2016). 544 
6. Calvi, L.M. et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425, 545 
841-846 (2003). 546 
7. Guidi, N. et al. Osteopontin attenuates aging-associated phenotypes of hematopoietic stem 547 
cells. EMBO J 36, 1463 (2017). 548 
8. Heazlewood, S.Y. et al. Megakaryocytes co-localise with hemopoietic stem cells and release 549 
cytokines that up-regulate stem cell proliferation. Stem Cell Res 11, 782-792 (2013). 550 
9. Zhao, M. et al. Megakaryocytes maintain homeostatic quiescence and promote post-injury 551 
regeneration of hematopoietic stem cells. Nat. Med. 20, 1321-1326 (2014). 552 
10. Bruns, I. et al. Megakaryocytes regulate hematopoietic stem cell quiescence through CXCL4 553 
secretion. Nat. Med. 20, 1315-1320 (2014). 554 
11. Mendez-Ferrer, S. et al. Mesenchymal and haematopoietic stem cells form a unique bone 555 
marrow niche. Nature 466, 829-834 (2010). 556 
12. Haylock, D.N. et al. Hemopoietic stem cells with higher hemopoietic potential reside at the 557 
bone marrow endosteum. Stem Cells 25, 1062-1069 (2007). 558 
13. Akunuru, S. & Geiger, H. Aging, Clonality, and Rejuvenation of Hematopoietic Stem Cells. 559 
Trends Mol Med 22, 701-712 (2016). 560 
14. Geiger, H., de Haan, G. & Florian, M.C. The ageing haematopoietic stem cell compartment. 561 
Nat Rev Immunol 13, 376-389 (2013). 562 
15. Morrison, S.J., Wandycz, A.M., Akashi, K., Globerson, A. & Weissman, I.L. The aging of 563 
hematopoietic stem cells. Nat. Med. 2, 1011-1016 (1996). 564 
16. Rossi, D.J. et al. Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc Natl 565 
Acad Sci U S A 102, 9194-9199 (2005). 566 
17. Kamminga, L.M. et al. Impaired hematopoietic stem cell functioning after serial 567 
transplantation and during normal aging. Stem Cells 23, 82-92 (2005). 568 
18. Beerman, I., Maloney, W.J., Weissmann, I.L. & Rossi, D.J. Stem cells and the aging 569 
hematopoietic system. Curr. Opin. Immunol. 22, 500-506 (2010). 570 
19. Maryanovich, M. et al. Adrenergic nerve degeneration in bone marrow drives aging of the 571 
hematopoietic stem cell niche. Nat. Med. (2018). 572 
20. Bockamp, E. et al. Tetracycline-controlled transgenic targeting from the SCL locus directs 573 
conditional expression to erythrocytes, megakaryocytes, granulocytes, and c-kit-expressing lineage-574 
negative hematopoietic cells. Blood 108, 1533-1541 (2006). 575 
21. Wilson, A. et al. Hematopoietic stem cells reversibly switch from dormancy to self-renewal 576 
during homeostasis and repair. Cell 135, 1118-1129 (2008). 577 
22. Walter, D. et al. Exit from dormancy provokes DNA-damage-induced attrition in 578 
haematopoietic stem cells. Nature 520, 549-552 (2015). 579 
23. Cabezas-Wallscheid, N. et al. Vitamin A-Retinoic Acid Signaling Regulates Hematopoietic 580 
Stem Cell Dormancy. Cell 169, 807-823 e819 (2017). 581 
 22 
24. Essers, M.A. et al. IFNalpha activates dormant haematopoietic stem cells in vivo. Nature 458, 582 
904-908 (2009). 583 
25. Bernitz, J.M., Kim, H.S., MacArthur, B., Sieburg, H. & Moore, K. Hematopoietic Stem Cells 584 
Count and Remember Self-Renewal Divisions. Cell 167, 1296-1309 e1210 (2016). 585 
26. Waskow, C. et al. Hematopoietic stem cell transplantation without irradiation. Nat Methods 586 
6, 267-269 (2009). 587 
27. Florian, M.C. et al. A canonical to non-canonical Wnt signalling switch in haematopoietic 588 
stem-cell ageing. Nature 503, 392-396 (2013). 589 
28. Florian, M.C. et al. Cdc42 activity regulates hematopoietic stem cell aging and rejuvenation. 590 
Cell Stem Cell 10, 520-530 (2012). 591 
29. Grigoryan, A. et al. LaminA/C regulates epigenetic and chromatin architecture changes upon 592 
aging of hematopoietic stem cells. Genome Biol 19, 189 (2018). 593 
30. Florian, M.C. et al. Aging alters the epigenetic asymmetry of HSC division   PLOS Biology 594 
(2018). 595 
31. Maryanovich, M., Takeishi, S. & Frenette, P.S. Neural Regulation of Bone and Bone Marrow. 596 
Cold Spring Harb Perspect Med (2018). 597 
32. Kusumbe, A.P. et al. Age-dependent modulation of vascular niches for haematopoietic stem 598 
cells. Nature 532, 380-384 (2016). 599 
33. Spencer, J.A. et al. Direct measurement of local oxygen concentration in the bone marrow of 600 
live animals. Nature 508, 269-273 (2014). 601 
34. Zhang, Y. et al. CXCR4/CXCL12 axis counteracts hematopoietic stem cell exhaustion 602 
through selective protection against oxidative stress. Sci Rep 6, 37827 (2016). 603 
35. Sugiyama, T., Kohara, H., Noda, M. & Nagasawa, T. Maintenance of the hematopoietic stem 604 
cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 605 
25, 977-988 (2006). 606 
36. Broxmeyer, H.E. et al. DEK regulates hematopoietic stem engraftment and progenitor cell 607 
proliferation. Stem Cells Dev 21, 1449-1454 (2012). 608 
37. Solaimani Kartalaei, P. et al. Whole-transcriptome analysis of endothelial to hematopoietic 609 
stem cell transition reveals a requirement for Gpr56 in HSC generation. J. Exp. Med. 212, 93-106 610 
(2015). 611 
38. Holmfeldt, P. et al. Functional screen identifies regulators of murine hematopoietic stem cell 612 
repopulation. J. Exp. Med. 213, 433-449 (2016). 613 
39. Borggrefe, T. & Oswald, F. The Notch signaling pathway: transcriptional regulation at Notch 614 
target genes. Cell. Mol. Life Sci. 66, 1631-1646 (2009). 615 
40. Kojika, S. & Griffin, J.D. Notch receptors and hematopoiesis. Exp. Hematol. 29, 1041-1052 616 
(2001). 617 
41. Guiu, J. et al. Hes repressors are essential regulators of hematopoietic stem cell development 618 
downstream of Notch signaling. J. Exp. Med. 210, 71-84 (2013). 619 
42. Shimizu, K. et al. Binding of Delta1, Jagged1, and Jagged2 to Notch2 rapidly induces 620 
cleavage, nuclear translocation, and hyperphosphorylation of Notch2. Mol. Cell. Biol. 20, 6913-6922 621 
(2000). 622 
43. Kopp, H.G., Hooper, A.T., Avecilla, S.T. & Rafii, S. Functional heterogeneity of the bone 623 
marrow vascular niche. Ann. N. Y. Acad. Sci. 1176, 47-54 (2009). 624 
44. Kopp, H.G. et al. Tie2 activation contributes to hemangiogenic regeneration after 625 
myelosuppression. Blood 106, 505-513 (2005). 626 
45. Zhou, B.O. et al. Bone marrow adipocytes promote the regeneration of stem cells and 627 
haematopoiesis by secreting SCF. Nat Cell Biol 19, 891-903 (2017). 628 
46. Baryawno, N., Severe, N. & Scadden, D.T. Hematopoiesis: Reconciling Historic 629 
Controversies about the Niche. Cell Stem Cell 20, 590-592 (2017). 630 
 23 
47. Maillard, I. et al. Canonical notch signaling is dispensable for the maintenance of adult 631 
hematopoietic stem cells. Cell Stem Cell 2, 356-366 (2008). 632 
48. Guo, P. et al. Endothelial jagged-2 sustains hematopoietic stem and progenitor reconstitution 633 
after myelosuppression. J. Clin. Invest. (2017). 634 
49. Luche, H., Weber, O., Nageswara Rao, T., Blum, C. & Fehling, H.J. Faithful activation of an 635 
extra-bright red fluorescent protein in "knock-in" Cre-reporter mice ideally suited for lineage tracing 636 
studies. Eur. J. Immunol. 37, 43-53 (2007). 637 
50. Schwenk, F., Baron, U. & Rajewsky, K. A cre-transgenic mouse strain for the ubiquitous 638 
deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res 23, 5080-639 
5081 (1995). 640 
51. Lis, R. et al. Conversion of adult endothelium to immunocompetent haematopoietic stem 641 
cells. Nature 545, 439-445 (2017). 642 
52. Elyaman, W. et al. Notch receptors and Smad3 signaling cooperate in the induction of 643 
interleukin-9-producing T cells. Immunity 36, 623-634 (2012). 644 
53. Angerer, P. et al. destiny: diffusion maps for large-scale single-cell data in R. Bioinformatics 645 
32, 1241-1243 (2016). 646 
54. McCarthy, D.J., Campbell, K.R., Lun, A.T. & Wills, Q.F. Scater: pre-processing, quality 647 
control, normalization and visualization of single-cell RNA-seq data in R. Bioinformatics 33, 1179-648 
1186 (2017). 649 
55. Brennecke, P. et al. Accounting for technical noise in single-cell RNA-seq experiments. Nat 650 
Methods 10, 1093-1095 (2013). 651 
56. Love, M.I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for 652 
RNA-seq data with DESeq2. Genome Biol 15, 550 (2014). 653 
57. Scialdone, A. et al. Computational assignment of cell-cycle stage from single-cell 654 
transcriptome data. Methods 85, 54-61 (2015). 655 
58. Lun, A.T., McCarthy, D.J. & Marioni, J.C. A step-by-step workflow for low-level analysis of 656 
single-cell RNA-seq data with Bioconductor. F1000Res 5, 2122 (2016). 657 
658 
 24 
Acknowledgment  659 
We thank Jose A. Cancelas (Cincinnati Children Hospital Medical Center, Cincinnati, Ohio, USA) for advice 660 
and critical reading of the manuscript. We thank Prof. Hans Joerg Fehling (Institute of Immunology, Ulm 661 
University, Germany) for kindly donating AcRFP and AcYFP mice and Dr. Yi Zheng (Cincinnati Children 662 
Hospital Medical Center, Cincinnati, Ohio, USA) for donating AcCFP mice. We thank the core facilities at 663 
Ulm University: Angelika Rück (Microscope Facility) for support with confocal and 2-photon microscopy, the 664 
Cell Sorting Facility and the Tierforschungszentrum (Animal Facility). Work in the laboratory of M.C.F. was 665 
supported by an Emmy Noether Grant (DFG), SFB1074 and FOR2674 (DFG) to M.C.F. M.S. was supported 666 
by a PhD Degree Scholarship of the Avicenna-Studienwerk. 667 
 668 
Author contributions 669 
MS and MCF performed and analyzed laboratory experiments. MS performed all histological experiments and 670 
microscopy analysis. JP conceived the computational model with assistance of WDB and performed 671 
bioinformatics analysis of scRNA-seq datasets with support from RK. KS and GM assisted in transplantation 672 
procedures, bleeding, supported in cell sorting and flow analysis procedures. AV performed single cell RNA-673 
seq sample preparation, supported in cell sorting and flow analysis procedures and performed in vitro co-674 
culture experiments. VS supervised mouse work and took care of breeding, ageing and preparation of the mice 675 
used for experiments. MS and MCF designed and interpreted experiments. JPM prepared scRNA-seq libraries 676 
from endothelial cells. NC-W supported with scRNA sequencing. NC-W, AT, MDM and RB supported all the 677 
experiments involving SCL-tTAxH2B-GFP double heterozygous mice. MAM developed the deep learning 678 
algorithm. HG supported in interpreting experiments and writing the manuscript. SMF supported with Nestin-679 
GFP mice and assisted in interpreting experiments. MS, JP and MCF wrote the manuscript. 680 
 681 
Competing Financial interests 682 
The authors declare no competing financial interests. 683 
 25 
Figure Legends 684 
Figure 1. Aged LR-HSCs are located in proximity to sinusoids. 685 
a, Schematic representation of the experimental setup: SCL-tTAxH2B-GFP mice were treated with DOX for 686 
18 months starting at 8 weeks of age. H2B-GFP signal is diluted by division and over time only dormant rarely 687 
diving cells retain the label. b, Cartoon scheme showing how distances between cells were measured. In 688 
immunostained whole-mount bones analyzed by 3D confocal microscopy < 10 µm distance from the HSC 689 
centroid defines the proximity: HSCs were considered in proximity to a niche cell when the distance from the 690 
centroid of an HSC to the edge of a niche cells was less than 10 µm, thus no cell can be found in-between. 691 
HSC radius 5 µm and smallest non-erythroblast BM cell radius >5 µm. c-e, Representative confocal whole-692 
mount images of old SCL-tTAxH2B-GFP humeral BM showing GFP+ CD150+ CD41- CD48- Lin- single LR-693 
HSC (c), single GFP- CD150+ CD41- CD48- Lin- nLR-HSC (d) and clustered nLR-HSCs (e) (arrowheads). LR-694 
HSCs maintain H2B-GFP+ nuclei (green). Vasculature is stained with FABP4 (magenta). HSCs stain positive 695 
for CD150 (red) but negative for all the other haematopoietic markers (CD41, CD48 and lineage are in grey). 696 
f, Pie chart depicting percentage of single or clustered nLR-HSCs and LR-HSCs present in humeral whole-697 
mount images. g, Mean distance of single LR-HSCs and single or clustered nLR-HSCs to the nearest 698 
vasculature. h, Percentage of single LR-HSCs, single and clustered nLR-HSCs in proximity (< 10 µm) to 699 
sinusoids (83.33%, 19.08%, 9.46%), arterioles/arteries (5.56%, 9.21%, 0.00%) and MKs (27.78%, 19.33%, 700 
5.33%). i, Representative 3D reconstruction of confocal whole-mount images of old SCL-tTAxH2B-GFP 701 
humeral BM showing a CD150+ CD41- CD48- Lin- LR-HSC (arrowhead) in proximity to sinusoidal 702 
vasculature. j, Pie chart showing percentage of the different HSC types which are adjacent to sinusoids (< 10 703 
µm, 29%, 57%, 14%). k, Mean distance of single LR-HSCs and single or clustered nLR-HSCs to the nearest 704 
endosteum. l, Mean distance of single LR-HSCs and single or clustered nLR-HSCs to the nearest MK. m, 705 
Confocal whole-mount images depicting a LR-HSC (arrowhead) in proximity to a MK. In f-h, and j-l, n = 245 706 
total HSCs from 6 mice, 51 longitudinal shaved humeral and femoral cross-section areas, 7 biological repeats. 707 
Data represent mean ± s.e.m. In g, k, l the statistical significance was assessed by Mann-Whitney-test. * p < 708 
0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. Scale bars 20 µm. See also Supplementary Figure 1, 2 709 
and Supplementary Video 1. 710 
 711 
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Figure 2. Aged HSCs are located more distant to most niche cells, but not to Nes-GFPlow cells and 712 
sinusoids, which are uniquely preserved upon ageing. 713 
a, b, Representative 3D confocal whole-mount images of longitudinally shaved C57BL/6 (WT) young (a) and 714 
old (b) femoral BM showing CD150+ (red) CD41- CD48- Lin- (white) HSCs in the endosteal area. Vasculature 715 
is stained i.v. with anti-PECAM1 and anti-VE-Cadherin (CD31 and CD144, blue) antibodies. Dashed lines 716 
denote the endosteum, arrows (yellow) show HSCs. c, Percentage of HSCs in the young and old femoral 717 
endosteal area (< 50 µm). d, Mean distance of HSCs to the young and old femoral endosteum (c, d, n = 232 718 
young HSCs from 56 areas and n = 495 old HSCs from 30 areas, 6 mice per group). e, Percentage of young 719 
and old HSCs in direct contact to Nes-GFPlow cells (< 10 µm) (n = 84 young HSCs from 7 areas and n = 135 720 
old HSCs from 5, 3 mice per group). f, 3D confocal whole-mount images of young and old femoral WT BM. 721 
Arrowheads show arterioles, arrows HSCs. Percentage of young and old HSCs adjacent to arterioles (< 10 722 
µm). g, 3D confocal whole-mount images of young and old femoral WT BM showing spatial relationship of 723 
HSCs (arrows) and sinusoids (blue). Percentage of young and old HSCs adjacent to sinusoids (< 10 µm), (f, g, 724 
n = 193 young HSCs from 39 areas and n = 397 old HSCs from 17 areas, 3 mice per group). i, j, Pie charts 725 
depicting percentage of endosteal and central BM isolated CD45- CD31- Nes-GFP+ cells from young and old 726 
Nes-GFP mice. k, Frequency of CD45- CD31- Nes-GFPhigh or Nes-GFPlow cells among nucleated cells from 727 
endosteal and central BM from young and old Nes-GFP mice (i-k n = 4 mice per group). l, Representative tile 728 
scanned and stacked whole-mount images of tibiae from young and old Nes-GFP mice. m, Frequency of 729 
CD41+ FSChigh MKs from young and old WT BM (n = 3-4 mice per group). n, Quantification of CD41+ MKs 730 
in z-stacked whole-mount images acquired from young and old long bones (n = 7 young and 9 aged 731 
longitudinal shaved cross-section areas, two mice per group). o, Frequency of CD45- CD31+ ECs from young 732 
and old WT endosteal BM (n = 4 mice per group). p, Schematic of a long bone showing epiphysis, metaphysis 733 
and diaphysis. (q) Epiphyseal/metaphyseal and (r) diaphyseal BM areas occupied by vasculature in young and 734 
old long bones (n = 3/9 and 3/13 areas, 3 mice per group). s, Whole-mount images showing vasculature (red) 735 
in tibial epiphysis/metaphysis and diaphysis from young and old mice. t-y, Quantification of 736 
epiphyseal/metaphyseal (t-v) and diaphyseal (w-y) BV diameter, length and orientation to the bone long axis 737 
(n = 96/296 young and n = 293/418 old BVs from 4-5 epiphyseal/diaphyseal areas, two mice per group). Data 738 
represent mean ± s.e.m. In d the statistical significance was assessed by Mann-Whitney-test in c, e, f, g, m, n, 739 
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o, q, r, t-y by Student’s t-tests and in k by two-way-ANOVA-test. * p < 0.05, ** p < 0.01, *** p < 0.001, **** 740 
p < 0.0001, n.s.= not significant. n = 2-3 biological repeats. Scale bars, 50 µm (a, b); 20 µm (f, g); 500 µm (l); 741 
100 µm (s). See also Supplementary Figure 3, 4, Supplementary Table 1, 2 and Supplementary Video 2-742 
5. 743 
 744 
Figure 3. HSC proximity to selected niche cells is not random. In young mice, transplanted HSCs lodge 745 
in at least two different functional niches, while in the aged the endosteal/arteriolar niche is functionally 746 
impaired. 747 
a, Observed (in situ) and expected (in silico) distances of HSCs towards the endosteum in young and aged 748 
mice. Statistical difference indicates a non-random distribution of HSCs in the in situ setting. b, c, Comparison 749 
of distances of HSCs towards Nes-GFPlow cells (b) or Nes-GFPhigh cells (c) in young and aged mice, within the 750 
in situ or in silico setting. For NesGFPlow cells, both observed and expected/random distance distributions show 751 
an increase in distance with ageing, while there is no shift in distance for Nes-GFPhigh cells. For simulation 752 
procedure and statistical analysis see Materials & Methods. d, Summary of changes in distance of HSCs 753 
towards different niche structures as observed in situ and as predicted by the computational model. e, Diffusion 754 
map representation of normalized gene expression data of aged LR-HSCs, aged LR-HSCs, young LR-HSCs 755 
and young HSCs (young data reanalyzed from23). e, Summary of the keras/TensorFlow deep learning analysis. 756 
Top-right panel: Validation prediction accuracy (y-axis) of the sequential model over 50 iterations (x-axis). 757 
Top-left panel: boxplot showing prediction accuracy after summarizing the 50 iterations by binning them into 758 
10 groups (5 iterations per bin). Middle-left panel: Median accuracy of the 10 groups are shown. Dotted line 759 
depicts a fitted linear model. Middle-right panel: Median accuracy of the ten groups (x-axis) are plotted against 760 
a sorted/ranked version. The dotted line shows a linear model recapitulating the significant linear increment of 761 
the model over the 50 iterations. Lower-left panel: boxplot showing overall accuracy of the model. Lower-762 
right panel: frequency distribution of the validation accuracy. f, Graphical representation of the confusion 763 
matrix where correctly classified (blue points) and misclassified (red points) HSCs are shown. Measured (Real 764 
class) represents empirical data membership while predicted (y-axis) represents the membership as determined 765 
by the keras/TensorFlow deep learning model. We observed an overall 82.5% prediction accuracy. g, 766 
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Correlation analysis showing relevance of the parameters to the classification model. The plots were generated 767 
after performing a bootstrap analysis (500 iterations) of correlation coefficient estimation. There was no 768 
significant difference between the parameters’ correlation coefficients. h, Scheme of the competitive BM 769 
transplantation experiment of CFP+ young and YFP+ aged HSCs into young and aged Rag2-/-gc-/-KitW/Wv 770 
recipient mice. i, j, Representative 3-dimensional confocal pictures of whole-mount femurs from young (i) and 771 
aged (j) recipient mice transplanted with CFP+ young and YFP+ aged HSCs. Donor-derived CFP+ young HSCs 772 
are indicated by cyan and donor-derived YFP+ aged HSCs by yellow arrowheads. Dashed lines denote the 773 
endosteum of the recipient (in i 1 unit = 45.23 µm, in j 1 unit = 45.72 µm). k, Relative distribution of CFP+ 774 
young and YFP+ old HSCs to the endosteum in bones of young and old recipients. (i, n = 210 CFP+ young and 775 
n = 30 YFP+ old HSCs from 31 areas, two mice per group; j, n = 80 CFP+ young and n = 27 YFP+ old HSCs 776 
from 30 areas HSCs, two mice per group). n = 2-4 biological repeats. See also Supplementary Figure 4, 5, 6 777 
and Supplementary Video 6. 778 
 779 
Figure 4. Jag2 maintains aged LR-HSCs at sinusoids. 780 
a, Diffusion map representation of normalized gene expression data of aged LR-HSCs, aged LR-HSCs, young 781 
LR-HSCs and young HSCs (young data reanalysed from23). b, Heatmap showing the relative expression levels 782 
of 1058 differentially expressed genes (rows) between aged nLR-HSCs and aged LR-HSCs (columns). c, GO 783 
(gene ontology) analysis of genes that are upregulated in LR-HSCs (detected using ToppGene). d, Rbpj and 784 
Hes1 are upregulated in LR-HSCs. Values related to single cells and referred to DESeq-normalized and 785 
baselined log(FPKM). Data are plotted as average population expression ±SD. e, Z-stacked IF images showing 786 
Jag2 expression (red) in sinusoidal vessels (blue) and perisinusoidal Nes-GFPlow cells (green) in central 787 
diaphyseal BM from young and old WT mice. f, Representative 3D confocal immunostaining of arteriolar 788 
(blue, CD31/CD144) and periarteriolar Nes-GFPhigh cells (green) of young and old WT endosteal BM showing 789 
Jag2 (red) signal (1 unit = 5.48 µm). g-i, Percentages of Nes-GFPhigh cells (g), Nes-GFPlow cells (h) and 790 
endothelial cells (i) expressing Dll1, Jag1 and Jag2 from young and old Nes-GFP mice (n = 2-5 mice per 791 
group). j, Cartoon scheme depicting the experimental set up. Aged mice were injected twice 24-hour apart 792 
with 15mg/kg of either Jag2 blocking antibody or isotype control antibody. 48 hours after the first injection, 793 
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mice were harvested and processed for whole mount histological analysis. k, Z-Stacked confocal images of 794 
distal-diaphyseal-femoral central BM from mice treated with Jag2 blocking antibody and isotype control 795 
antibody. Scale bars, 100 µm. l, Percentage of clustered HSCs in cluster imaged in distal-diaphyseal-femoral 796 
central BM whole-mount preparations of mice treated with Jag2 blocking antibody and isotype control 797 
antibody showing HSCs (CD150+ in red and exclusion markers CD48, CD41, LIN in white, n = 1265 and n = 798 
109 HSCs from 4 and 3 areas; 3 aged mice/group). m, Percentage of Ki-67+ HSCs present in distal-diaphyseal-799 
femoral central BM whole-mount images of Jag2 blocking antibody and isotype control antibody treated aged 800 
mice (n = 966 and n = 109 HSCs per group from 3 areas per group; 2/3 mice/group). n, Percentage of clustered 801 
HSCs in proximity to sinusoids (< 10 µm) in distal-diaphyseal-femoral central BM whole-mount images of 802 
mice treated with Jag2 blocking antibody and isotype control antibody (n = 1113 and n = 109 HSCs from 4 803 
and 3 areas, 3 mice/group). In g-i and l-n data represent mean ± s.e.m and the statistical significance was 804 
assessed by Student’s t-tests. * p < 0.05, ** p < 0.01. n = 2-5 biological repeats. Scale bars, 20 µm (e). See 805 
also Supplementary Figure 4, 5, 6 and Supplementary Video 6. 806 
 807 
Figure 5. 5-FU treatment specifically disrupts sinusoidal niches and impairs haematopoiesis and 808 
survival of aged mice. 809 
a, Z-stacked whole-mount images showing vasculature (red), nucleated cells (4′,6-diamidino-2-phenylindole, 810 
DAPI) and erythroid cells (green) in long bones from young and old mice 4 days after 5-FU administration 811 
and non-treated controls. Endosteal BM (eBM) < 50 µm and central BM (cBM) ³ 50µm from the endosteum 812 
(dashed line). b, c, Quantification of (b) BV diameter and (c) total nucleated cell (NC) numbers per volume in 813 
stacked images in central BM (³ 50 µm from endost) from 5-FU treated (4d) and non-treated young and old 814 
mice (means of (b) n = 135/81/151/85 BVs from 3 areas, two mice per group). d, Images showing arterioles 815 
(yellow arrowheads) and sinusoids (blue arrowheads) in BM from 5-FU treated and non-treated young and old 816 
mice; CD31/CD144 (red). e, f, Quantification of (e) BV diameter and (f) total nucleated cell (NC) numbers 817 
per volume in z-stacked images in endosteal BM (< 50 µm from endost) from 5-FU treated (4d) and non-818 
treated young and old mice (means of (e) n = 46/35/48/36 BVs from 3 areas, two mice per group). g, 819 
Representative flow density plot of old control and 5-FU treated Nes-GFP cells. h, Percentage of absolute 820 
number of Nes-GFPlow and Nes-GFPhigh cells in BM of 5-FU treated young and old mice to control (n = 3/4 821 
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mice per group). i, Confocal images of young, old and aged YFP+ HSCs prior transplanted in young Rag2-/-gc-822 
/-KitW/Wv recipient femoral central BM 4 days after 5-FU treatment. Arrows (yellow) show HSCs (CD150+ 823 
CD41- CD48- Lin-, for the transplanted setting CD150+ YFP+ CD41- CD48- Lin-). Ki-67 (green) and YFP 824 
(yellow). j, pie charts depicting percentage of Ki-67+ and Ki-67- HSCs present in long bone whole-mount 825 
images in BM of young, old and aged YFP+ HSCs prior transplanted in young Rag2-/-gc-/-KitW/Wv mice 4 days 826 
after 5-FU administration. (i, j, n = 52/193/86 HSCs, 3 mice per group). k, l, Whole blood cell (WBC in K/µl) 827 
count (k) and survival (l) after 5-FU administration of young and old mice; survival of old control mice is also 828 
shown. Old mice after 5-FU administration had median survival of 145 days (n = 12 mice each group). m, 829 
Blood chimerism kinetics of overall engrafted donor-derived cells in transplantations of 5-FU preconditioned, 830 
lethally irradiated (11 Gy) and control young and aged recipient mice with young or old YFP+ donor HSCs (n 831 
= 4-6 mice per group). n, Stacked whole-mount images showing vasculature (blue) and Jag2 expression (red) 832 
in long bones from young and old mice 30 days after 5-FU administration and non-treated controls. o, Ratio 833 
of Jag2 signal volume to DAPI signal volume in z-stacked images in BM from 5-FU treated (30d) and non-834 
treated young and old mice (n = 16/15/15/14 areas, 2-3 mice per group). p, Percentage of HSCs from young 835 
and old mice 30 days after 5-FU administration and non-treated controls adjacent to sinusoids, arterioles (< 10 836 
µm) and in the endosteal area (> 50 µm) (n = 84/84/80 young 5-FU 30d HSCs from 30 areas, n = 142/142/156 837 
old 5-FU 30d HSCs from 27 areas, n = 193/193/232 young HSCs from 39/39/56 areas and n = 397/397/495 838 
old HSCs from 17/17/30 areas, 3-6 mice per group). In b, c, e, f, h, k, o, p data represent mean ± s.e.m. In b, 839 
c, e, f, h, o, p the statistical significance was assessed by Student’s t-tests, in k by two-way-ANOVA-test in l 840 
by log-rank (Mantel-Cox) test. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, n.s.= not significant. 841 
n = 2-4 biological repeats. Scale bars, 100 µm (a); 20 µm (d, i); 50 µm (n). See also Supplementary Figure 842 
7 and Supplementary Table 4. 843 
 844 
Supplementary Figure 1: Aged LR-HSC pool expand less than aged nLR-HSCs and are functional long 845 
term stem cells. 846 
a, Representative FACS dot plots of the gating strategy for LR-HSCs (Lin- c-Kit+ Sca-1+ Flk2- CD34- CD48- 847 
CD150+ H2B-GFP+) of young and aged not DOX treated H2B-GFP, and young and aged DOX treated SCL-848 
tTAxH2B-GFP lineage-depleted BM cells and schematic representation of the experimental setups. b, 849 
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Frequency of different HSPC subpopulations, LR-HSCs and nLR-HSCs among BM cells in young and old 850 
SCL-tTAxH2B-GFP mice after 2 and 18-months of DOX chase, respectively. 851 
 c, Percentages of young and old LR-HSCs in BM cells in DOX treated SCL-tTAxH2B-GFP mice. d, Similar 852 
frequency of old LSK CD34- Flk2- HSCs and old LSK CD34- Flk2- CD48- CD150+ HSCs among BM cells. e, 853 
Fold expansion of different HSPC subpopulations, LR-HSCs and nLR-HSCs with ageing. f, Experimental 854 
setup of single aged LR-HSC transplantation in Rag2-/-gc-/-KitW/Wv recipient mouse and gating strategy. g, Pie 855 
chart showing percentage of functional long-term HSCs among single transplanted aged LR-HSCs. h, Blood 856 
chimerism kinetics of overall engrafted donor-derived cells and of each donor-derived lineage (B cells, T cells 857 
and myeloid cells) with single donor old LR-HSCs. Data represent mean ± s.e.m. In b-e, n = 4 young and 5 858 
aged mice. In g, n = 7 recipient mice. The statistical significance was assessed by Student’s t-test. * p < 0.05. 859 
 860 
Supplementary Figure 2: Aged LR-HSCs show higher regenerative capacity and are polar and young 861 
LR-HSCs are located in central and endosteal BM. 862 
a, Scheme of the transplantation experiment setup. b, Blood chimerism kinetics of overall engrafted donor-863 
derived cells and of each donor-derived lineage (B cells, T cells and myeloid cells) during primary and 864 
secondary transplants with donor old LR-HSCs and donor old nLR-HSCs. c, Frequency of old nLR-HSCs and 865 
old LR-HSCs donor contribution to total white blood cells (WBCs) in PB in Rag2-/-gc-/-KitW/Wv recipient mice. 866 
d, Frequency of LR- and nLR- LT-HSCs in BM among donor-derived (SCL-tTAxH2B-GFP mice after 18-867 
months of DOX chase) LSK cells in Rag2-/-gc-/-KitW/Wv recipient mice. e, Percentage of B cells, T cells and 868 
myeloid cells among donor derived cells. f, Representative single-cell IF images showing the distribution of 869 
tubulin (green) and Cdc42 (red), in old LR-HSCs and old nLR-HSCs. Nuclei, DAPI (blue). g, Representative 870 
3D reconstructed single-cell IF confocal images showing the distribution of H4K16ac (magenta) in old LR-871 
HSCs (polar) and old nLR-HSCs (apolar). Nuclei, DAPI (blue). h, i, Percentage of polar distribution of Cdc42, 872 
H4K16ac and tubulin in (h) old LR-HSCs and old nLR-HSCs and in (i) young LR-HSCs and young nLR-873 
HSCs (n = 68/103 old/young LR-HSCs and 78/84 old/young nLR-HSCs from 4/3 different old/young mice 874 
for Cdc42; 104/80 old/young LR-HSCs and 120/82 old/young nLR-HSCs from 4/3 different old/young mice 875 
for H4K16ac and 172/118 old/young LR-HSCs and 198/116 old/young nLR-HSCs from 7/5 different 876 
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old/young mice for Tubulin). j, Representative stacked whole-mount images of young SCL-tTAxH2B-GFP 877 
femoral BM showing label retaining cells (green) and vasculature (blue). k, 3D reconstruction of confocal 878 
whole-mount images of young SCL-tTAxH2B-GFP femoral BM showing a CD150+ H2B-GFP+ LR cell in 879 
proximity to arterial vasculature (arrowheads) in the endosteal area. l, m, Distinction of sinusoids and arterioles 880 
in (l) FABP4 (red) in situ stained and (m) CD31/CD144 (red) i.v. stained BM: arterioles (yellow arrowheads) 881 
have small diameter with continuous staining (continuous basal lamina) and have parallel orientation to the 882 
long axis of the bone, sinusoids (blue arrowheads) present relatively larger diameter with spotted staining 883 
(fenestrated basal lamina) and are mostly transverse to the long axis. (l) Nuclei, DAPI (blue). n, o, 884 
Colocalization of (n) sinusoids and (o) arterioles/arteries in FABP4 (green) in situ stained and CD31/CD144 885 
(red) i.v. stained BM. c-e, n = 12-14 initial recipient mice in total from 3 different aged donor mice. The 886 
statistical significance was assessed by Student’s t-test. * p < 0.05, ** p < 0.01. Scale bars 100 µm (j); 20 µm 887 
(k-o). 888 
 889 
Supplementary Figure 3: HSC proximity to selected niche cell types is altered upon ageing. 890 
a, Distance between young and old HSCs to the nearest endosteum (n = 192 young HSCs from 36 areas and n 891 
= 432 old HSCs from 17 areas, 3 mice per group), b, Confocal images of young and old whole-mount WT 892 
femoral BM showing HSCs (arrows) and MKs. c, Percentage of young and old HSCs in direct proximity to 893 
MKs (< 10 µm). d, Mean distance of young and old HSCs to the nearest MK. e, Distance between young and 894 
old HSCs to the nearest megakaryocyte (c-e, n = 177 young HSCs from 34 areas and n = 163 old HSCs from 895 
10 areas, 3 mice per group). f, Confocal whole-mount images of young and old sternal Nes-GFP mice BM. 896 
Arrows (yellow) show HSCs. Nuclei, DAPI (blue). g, Percentage of young and old HSCs in direct contact to 897 
Nes-GFPhigh cells (< 1 µm). h, Mean distance of young and old HSCs to the nearest Nes-GFPhigh cell (g, h, n 898 
= 137 young HSCs from 9 areas and n = 275 old HSCs from 5, 3 mice per group). i, Mean distance of young 899 
and old HSCs to the nearest Nes-GFPlow cell (i, n = 84 young HSCs from 7 areas and n = 135 old HSCs from 900 
5, 3 mice per group). j, k, Distance between young and old HSCs to the nearest (j) Nes-GFPhigh cell (n = 137 901 
young HSCs from 9 areas and n = 275 old HSCs from 5 areas) and (k) Nes-GFPlow cell (n = 84 young HSCs 902 
from 7 areas and n = 135 old HSCs from 5 areas) (3 mice per group). l, Whole-mount confocal images revealing 903 
the overlap of perivascular LepR+ cells (red) and Nes-GFPlow cells (green) surrounding sinusoidal vessels 904 
 33 
(blue) in central BM of Nes-GFP mice. m, Percentage of young and old HSCs adjacent to perivascular LepR+ 905 
cells (< 10 µm). n, Mean distance of young and old HSCs to the nearest perivascular LepR+ cell. o, Distance 906 
between young and old HSCs to the nearest perivascular LepR+ cell (m-o, n = 96 young HSCs from 12 areas 907 
and n = 147 old HSCs from 12 areas, two mice per group). p, Percentage of young and old HSCs adjacent to 908 
BM vasculature (< 10 µm). q, Mean distance of young and old HSCs to the nearest vasculature. r, Distance 909 
between young and old HSCs to the nearest vasculature (p-r, n = 193 young and n = 397 old HSCs, 3 mice 910 
per group). Data represent mean ± s.e.m. In d, h, i, n, q the statistical significance was assessed by Mann-911 
Whitney-test, in a, e, j, k, n, o, r the statistical significance was assessed by two-way-ANOVA-test and in c, 912 
g, m, p by Student’s t-tests. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, n.s.= not significant. n = 913 
3 biological repeats. Scale bars, 40 µm (f); 20 µm (b, l). 914 
 915 
Supplementary Figure 4: HSC proximity to selected niche cell types is not random. 916 
a, Confocal images of WT old femoral BM. Arrow (yellow) shows Ki-67+ (green) HSC. b, Pie charts depicting 917 
percentage of Ki-67+ and Ki-67- HSCs (CD150+ CD41- CD48- Lin-) present in femoral whole-mount images 918 
in BM of WT young and old mice (n = 43 young and n = 140 old HSCs, 3 mice per group). c, 2-photon 919 
microscopy images showing Nes-GFP+ cells (green) concentrated at the endosteum of young and aged Nes-920 
GFP mouse BM. Bone (collagen, white) depiction was generated with second-harmonic generation 921 
microscopy (1 unit = 13.53 µm). d, Representative stacked whole-mount images of WT femoral BM showing 922 
CD41+ (yellow) MKs and vasculature (red). e, Confocal whole-mount image of WT femoral BM showing 923 
perisinusoidal CD41+ (yellow) MKs around sinusoids (red). f, Representative 3D reconstruction for volume 924 
occupancy measurements of CD31+ CD144+ ECs in femoral whole-mount images. g, Epiphyseal/metaphyseal 925 
and diaphyseal CD31+ CD144+ ECs volume occupancy in young and old long bone BM (n = 3/9 and 3/13 926 
areas, 3 mice per group). Data represent mean ± s.e.m. In g the statistical significance was assessed by 927 
Student’s t-tests. * p < 0.05, n.s.= not significant. n = 2-3 biological repeats. Scale bars, 20 µm (a, e); 100 µm 928 
(d). h, Generation of binary structure maps and depiction of the simulation process. i-k, Observed (in situ) and 929 
expected (in silico) distances of HSCs towards Nes-GFPhigh cells (i), Nes-GFPlow cells (j) or MKs (k) in young 930 
and aged mice. Statistical difference indicates a non-random distribution of HSCs in the in situ setting. l-m, 931 
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Comparison of distances of HSCs towards the endosteum (l) or MKs (m) in young and aged mice, within the 932 
in situ or in silico setting. With ageing an increase in distance towards the endosteum is both seen in situ and 933 
predicted by the random model. For MKs an increased distance is observed in situ, while the model would 934 
predict no alteration. n, A representative plot showing a case wise analysis of parameters in either supporting 935 
(green) or contradicting (red) that a given sample is aged or young HSC. Case numbers are indicated, along 936 
with label (Yes=Aged; No=Young). Model Probability and level of explanation of the fit are also given for 937 
each case. For simulation procedure and statistical analysis see Materials & Methods. 938 
 939 
Supplementary Figure 5: Case wise analysis for old and young HSCs. A representative plot showing a case 940 
wise analysis of parameters in either supporting (green) or contradicting (red) that a given sample is aged or 941 
young HSC. Case numbers are indicated, along with label (Yes=Aged; No=Young). Model Probability and 942 
level of explanation of the fit are also given for each case. 943 
 944 
Supplementary Figure 6: In young mice, transplanted HSCs lodge in at least two different functional 945 
niches, while in the aged the endosteal/arteriolar niche is functionally impaired. 946 
a, Confocal images of whole-mount femurs from aged recipient mice transplanted with CFP+ young and YFP+ 947 
aged HSCs. Arrows (white) show donor-derived CFP+ young and YFP+ aged HSCs. b, Percentage of CFP+ 948 
young and YFP+ old HSCs in young and old recipients adjacent to arterioles, sinusoids and megakaryocytes 949 
(< 10 µm) and in the endosteal area (< 50 µm) from femoral whole-mount immunofluorescence images. c, d, 950 
Pie charts depicting percentage of CFP+ young and YFP+ old HSCs in the endosteal/arteriolar and 951 
sinusoidal/megakaryocytic niche present in long bone whole-mount images of young (c) and old (d) recipients. 952 
e, f, Relative distribution of CFP+ young and YFP+ old HSCs to the endosteum in bones of young (e) and old 953 
(f) recipients. (c, e, n = 210 CFP+ young and n = 30 YFP+ old HSCs from 31 areas, two mice per group; d, f, n 954 
= 80 CFP+ young and n = 27 YFP+ old HSCs from 30 areas HSCs, two mice per group). g, h, Percentage of 955 
engraftment, T cells, B cells and myeloid cells from CFP+ young and YFP+ aged donor HSCs in peripheral 956 
blood of young recipient (g) (n = 9 mice each group) and old recipient mice (h) (n = 5 mice each group). i, 957 
Overview of the single cell RNAseq experimental layout. j-o, Histone variants (j) H2afz, (k) H3f3a and HSC 958 
regulators (l) Cxcr4, (m) Dek, (n) Gpr56 and (o) Ctnnb1 are upregulated in LR-HSCs. Values related to single 959 
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cells and referred to DESeq-normalized and baselined log(FPKM). Data are plotted as average population 960 
expression ±SD. In b, g, h data represent mean ± s.e.m and the statistical significance was assessed by 961 
Student’s t-tests. * p < 0.05. n = 4 biological repeats. Scale bars, 10 µm (a). 962 
 963 
 964 
Supplementary Figure 7: Endothelial Jag2 maintains aged LR-HSCs at sinusoids. 965 
a, Relative frequency of endothelial and Nes-GFPlow cells expressing Jag2 in BM of young and old Nes-GFP 966 
mice (n = 2-5). b, IF images showing Jag1 expression (red) in sinusoidal vessels (blue) and Nes-GFPlow cells 967 
(green) in BM from young and old Nes-GFP mice. DAPI (white). c, Overview of the in vitro co-culture 968 
experiments with blocking endothelial-derived Jag2. d, Epifluorescence images showing co-culture of YFP+ 969 
HSCs (green) and endothelial cells. Scale bars, 20µm (di); zoomed inset 10 µm (dii). e, Number of YFP+ HSCs 970 
after treatment with Jag2 blocking antibody and with isotype control. YFP+ HSCs samples were either assayed 971 
in co-culture with freshly prepared endothelial cells or alone (n = 6-3). f, Representative FACS dot plots of the 972 
gating strategy for YFP+ HSCs in vitro co-culture experiments with endothelial cells and blocking antibody 973 
Jag2. g, Z-Stacked confocal whole-mount images of femoral BM from mouse treated with Jag2 blocking 974 
antibody or isotype control. Samples were stained with the same secondary antibody (red). Vessels are stained 975 
with CD31 and CD144 (blue). h, Pie charts depicting percentage of Ki-67+ and Ki-67- HSCs present in distal-976 
diaphyseal-femoral central BM whole-mount images of Jag2 blocking antibody and isotype control 977 
antibody treated mice (n = 966 and n = 109 HSCs per group from 3 images). i, Representative 3D 978 
reconstruction of confocal whole-mount images showing sinusoidal (blue) location of Ki-67+ (red dots) and 979 
Ki-67- (yellow dots) HSCs present in distal-diaphyseal-femoral central BM of Jag2 blocking antibody treated 980 
mice (1 unit = 45.72 µm). j, Percentage of Ki-67+ HSCs adjacent to sinusoids (< 10 µm) in distal-diaphyseal-981 
femoral central BM whole-mount images in BM of mice treated with Jag2 blocking antibody and isotype 982 
control antibody (n = 472 and n = 28 HSCs from 3 areas per group). k, Percentage of clustered HSCs adjacent 983 
to sinusoids (< 10 µm) in distal-diaphyseal-femoral central BM whole-mount images of mice treated with Jag2 984 
blocking antibody and isotype control antibody (n = 653 and n = 28 HSCs from 4 and 3 areas). Data represent 985 
mean ± s.e.m. In a, e, j, k the statistical significance was assessed by Student’s t-tests. n = 2-6 biological 986 
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repeats. Scale bars, 20 µm (b), 10 µm (di), 10 µm (dii), 50 µm (g). 987 
 988 
Supplementary Figure 8: Impairment of the sinusoidal niche after 5-FU administration. 989 
a, Overview of the 5-FU experimental layout. b, Confocal images of 5-FU treated young femoral mice BM 990 
show cycling Ki-67+ (green) CD150+ (red) CD41 CD48 Lin+ (white) clusters of MPPs. c, Experimental layout 991 
of transplantation of aged YFP+ HSCs in young Rag2-/-gc-/-KitW/Wv recipient mice and 5-FU administration. d, 992 
Red blood cell count (RBC), myeloid (Gr1+, Mac1+), B cell (B220) and T cell (CD3) frequencies in PB of 5-993 
FU treated young and old mice (n = 12 mice each group). e, Cartoon scheme depicting experiments with 994 
transplantations of 5-FU preconditioned, lethally irradiated (11 Gy) and control young and aged recipient mice 995 
with young or old YFP+ donor HSCs. f, Percentage of engraftment from YFP+ HSCs in peripheral blood of 996 
young and aged control and 5-FU preconditioned recipient mice (n = 4-6 mice per group). g, Quantification of 997 
BV diameter and per volume in stacked images in central BM (³ 50 µm from endost) from 5-FU treated (30d) 998 
and non-treated young and old mice (n = 135/162/151/142 BVs from 3 areas, two mice per group). h, Z-stacked 999 
whole-mount images showing vasculature (CD31/CD144) in long bones from young and old mice 30 days 1000 
after 5-FU administration and non-treated controls. i, t-SNE representation of gene expression data of young 1001 
and aged CD31+ endothelial cells. j, Heatmap of differentially expressed genes (FDR adjusted p-value < 0.1). 1002 
Data shows log-transformed, size-factor normalized and batch corrected expression. k, Diffusion map 1003 
representation of cell cycle states of young and aged CD31+ endothelial cells. Cell cycle partitioning was 1004 
performed based on gene expression data. l, Pie charts depicting percentage of Ki-67+ and Ki-67- HSCs present 1005 
in long bone whole-mount images in BM of WT young and old mice 30 days after 5-FU administration (n = 1006 
80 young HSCs and n = 156 old HSCs, 3 mice per group). m, Frequency of HSCs and LSKs among BM cells 1007 
in control and 30-day-5-FU treated young and aged mice (n =6 mice per group). Data represent mean ± s.e.m. 1008 
In d the statistical significance was assessed by two-way-ANOVA-test. In f, g, m, the statistical significance 1009 
was assessed by Student’s t-tests. * p < 0.05, ** p < 0.01, *** p < 0.001. Scale bars, 100 µm (h); 50 µm (b).  1010 
 1011 
Supplementary Figure 9: Summary cartoon scheme and gating strategies. 1012 
a, Cartoon scheme depicting alterations of the aged niches. Aged HSCs compared to young are located more 1013 
distant to the endosteum, to megakaryocytes, to arterioles and to periarteriolar Nes-GFPhigh cells but not to 1014 
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Nes-GFPlow cells and sinusoids. With ageing megakaryocytes are increased. Endothelial cells and 1015 
endosteal/periarteriolar Nes-GFPhigh cells are dramatically reduced. The anatomy and morphology of arteries 1016 
and arterioles in the aged epiphysis is massively changed. The morphology, anatomy and numbers of 1017 
diaphyseal vessels, which are comprised mainly of sinusoids, and perisinusoidal Nes-GFPlow cells are not 1018 
affected by ageing. Also, a significant increase in the distance of aged HSCs from arterioles compared to young 1019 
is detected. The data convey that the sinusoidal/Nes-GFPlow cells localization and structure are uniquely 1020 
preserved upon ageing. LR-HSCs, which represent in aged mice the population of aged HSCs with the highest 1021 
regenerative potential, cell polarity and with non-clustering phenotype, were exclusively found at sinusoidal 1022 
niches. Importantly, Jag2 plays a functional role in the maintenance of proximity and quiescence of stem cells 1023 
at sinusoids. b, Representative gating strategy for Nes-GFP high and low BM cells; c, Gating strategy for 1024 
megakaryocytes; d, Gating strategy for endothelial cells; e, Gating strategy for PB cells. Representative 1025 
example of B220, CD3, Mac-1 and Gr-1 staining profile of white blood cells from an aged C57Bl6 mouse 1026 
(more than 100-week-old). 1027 
Supplementary Table 1: Total numbers of young and old HSCs in whole-mount images with endosteum and 1028 
numbers of young and old HSCs residing in the endosteal area (< 50 µm to the endosteal surface).	1029 
Supplementary Table 2: Total numbers of young and old HSCs in Ki-67 stained whole-mount images and 1030 
numbers of young and old HSCs and numbers of Ki-67+ young and Ki-67+ old HSCs < 50 µm distant to 1031 
vasculature, in the endosteal area (< 50 µm to the endosteal surface), in proximity to sinusoids (< 10 µm), in 1032 
proximity to arterioles/arteries (< 10 µm) and in proximity to megakaryocytes (< 10 µm) and numbers of HSCs 1033 
overlapping with more niches. 1034 
 1035 
Supplementary Table 3: Genes upregulated in aLR-HSCs compared to anLR-HSCs. Genes are listed up 1036 
to 3.0 fold change (FC). The p-value is also indicated alongside.  1037 
 1038 
Supplementary Table 4: Differentially expressed genes between young and aged CD31+ cells. Genes are 1039 
listed up to a FDR adjusted p-value of 0.25 (padj < 0.10 considered significant).  1040 
 1041 
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Supplementary Video 1: Old LR-HSC in proximity to a sinusoid.  1042 
3D reconstruction of confocal high resolution whole-mount images of DOX treated old SCL-tTAxH2B-GFP 1043 
humeral BM showing a single phenotypic CD150+ (red) CD41- CD48- Lin- (white) HSC in proximity to a 1044 
sinusoidal vessel (FABP4, magenta). H2B-GFP+ nuclei (green).  1045 
 1046 
Supplementary Video 2: Young HSC in physical association to an arteriole.  1047 
3D reconstruction of confocal high resolution whole-mount images of young femoral WT BM showing a single 1048 
phenotypic CD150+ (red) CD41- CD48- Lin- (white) HSC in physical association to an arteriole (CD31 and 1049 
CD144, blue). 1050 
 1051 
Supplementary Video 3: Old HSCs are located distant to arterioles.  1052 
3D reconstruction of confocal high resolution whole-mount images of old femoral WT BM showing two 1053 
phenotypic CD150+ (red) CD41- CD48- Lin- (white) HSCs located distant to an arteriole (CD31 and CD144, 1054 
blue). Yellow line marks the arteriolar vessel. 1055 
 1056 
Supplementary Video 4: Young HSC in proximity to a sinusoid.  1057 
3D reconstruction of confocal high resolution whole-mount images of young femoral WT BM showing a single 1058 
phenotypic CD150+ (red) CD41- CD48- Lin- (white) HSC in proximity to a sinusoidal vessel (CD31 and 1059 
CD144, blue). 1060 
 1061 
Supplementary Video 5: Old HSCs adjacent to a sinusoidal vessel.  1062 
3D reconstruction of confocal high resolution whole-mount images of old femoral WT BM showing two 1063 
phenotypic CD150+ (red) CD41- CD48- Lin- (white) HSCs in proximity to a sinusoidal vessel (CD31 and 1064 
CD144, blue) 1065 
 1066 
Supplementary Video 6: Old perisinusoidal LRC in proximity to a sinusoidal Jag2+ cell 1067 
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3D reconstruction of confocal high resolution whole-mount images of DOX treated old SCL-tTAxH2B-GFP 1068 
humeral BM showing a single H2B-GFP+ LRC (green) in proximity to a Jag2+ cell (red) at a sinusoidal vessel 1069 
(FABP4, blue).  1070 
Data availability 
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Code and algorithm generated during this study are included in this published article 
(and its supplementary information files) or are available from the corresponding author 
on reasonable request. 
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